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A B S T R A C T
Background
Cataract is the leading cause of blindness in the world, and cataract surgery is one of the most commonly performed operations in the
Western world. Preferred surgical techniques have changed dramatically over the past half century with associated improvements in
outcomes and safety. Femtosecond laser platforms that can accurately and reproducibly perform key steps in cataract surgery, including
corneal incisions, capsulotomy and lens fragmentation, are now available. The potential advantages of laser-assisted surgery are broad,
and include greater safety and better visual outcomes through greater precision and reproducibility.
Objectives
To compare the effectiveness of laser-assisted cataract surgery with standard ultrasound phacoemulsification cataract surgery by gathering
evidence on safety from randomised controlled trials (RCTs).
Search methods
We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 4), Ovid MEDLINE, Ovid
MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to May
2016), EMBASE (January 1980 toMay 2016), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January
1982 toMay 2016), the ISRCTNregistry (www.isrctn.com/editAdvancedSearch),ClinicalTrials.gov (www.clinicaltrials.gov), theWorld
Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en) and the U.S.
Food and Drugs Administration (FDA) website (www.fda.gov). We did not use any date or language restrictions in the electronic
searches for trials. We last searched the electronic databases on 10 May 2016.
Selection criteria
We included randomised controlled trials where laser-assisted cataract surgery was compared to standard ultrasound phacoemulsification
cataract surgery. We graded the certainty of the evidence using GRADE.
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Data collection and analysis
Two review authors independently screened the search results, assessed risk of bias and extracted data using the standard methodological
procedures expected by Cochrane. The primary outcome for this review was intraoperative complications in the operated eye, namely
anterior capsule and posterior capsule tears. The secondary outcomes were visual acuity (corrected distance visual acuity (CDVA) and
uncorrected distance visual acuity (UDVA)), refractive outcomes, quality of vision (as measured by any validated visual function score),
postoperative complications and cost-effectiveness.
Main results
We included 16 RCTs conducted in Germary, Hungary, Italy, India, China and Brazil that enrolled a total of 1638 eyes of 1245 adult
participants. Overall, the studies were at unclear or high risk of bias. In 11 of the studies the authors reported financial links with the
manufacturer of the laser platform evaluated in their studies. Five of the studies were within-person (paired-eye) studies with one eye
allocated to one procedure and the other eye allocated to the other procedure. These studies were reported ignoring the paired nature
of the data.
The number of anterior capsule and posterior capsule tears reported in the included studies for both laser cataract surgery and manual
phacoemulsification cataract surgery were low. There were four anterior capsule tears and one posterior capsule tear in 1076 eyes reported
in 10 studies (2 anterior capsule tears in laser arms, 2 anterior capsule tears and 1 posterior capsule tear in standard phacoemulsification
arms). We are very uncertain as to the effect of laser-assisted surgery compared to standard phacoemulsification surgery with respect
to these two outcomes. For postoperative cystoid macular oedema and elevated postoperative intraocular pressures, again the evidence
was inconclusive (odds ratio (OR) 0.58, 95% confidence interval (CI) 0.20 to 1.68; 957 eyes, 9 studies, low certainty evidence; and
OR 0.57, 95% CI 0.11 to 2.86; 903 eyes, 8 studies, low certainty evidence).
We found little evidence of any important difference in postoperative visual acuity between laser-assisted and standard phacoemulsi-
fication arms. There was a small advantage for laser-assisted cataract surgery at six months in CDVA. However, the mean difference
(MD) was -0.03 logMAR (95% CI -0.05 to -0.00; 224 eyes, 3 studies, low certainty evidence) which is equivalent to 1.5 logMAR
letters and is therefore, clinically insignificant. No studies reported patient-reported outcome measures such as visual function.
There were no data reported on costs or resource use but three studies reported the time taken to do the surgery. There was little
evidence of any major difference between the two procedures in this respect (MD 0.1 minutes, 95% CI -0.02 to 0.21; 274 eyes, low
certainty evidence).
Authors’ conclusions
The evidence from the 16 randomised controlled trials RCTs included in this review could not determine the equivalence or superiority
of laser-assisted cataract surgery compared to standard manual phacoemulsification for our chosen outcomes due to the low to very
low certainty of the evidence available from these studies. As complications occur rarely, large, adequately powered, well designed,
independent RCTs comparing the safety and efficacy of laser-assisted cataract surgery with standard phacoemulsification cataract surgery
are needed. Standardised reporting of complications and visual and refractive outcomes for cataract surgery would facilitate future
synthesis. Data on patient-reported outcomes and cost-effectiveness are needed. Paired-eye studies should be analysed and reported
appropriately.
P L A I N L A N G U A G E S U M M A R Y
Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery
What is the aim of this review?
The aim of this Cochrane Review was to find out what the benefits and harms of laser-assisted cataract surgery are compared with
standard ultrasound phacoemulsification cataract surgery. Cochrane researchers collected and analysed all relevant studies to answer
this question and found 16 studies.
Key messages
There is currently not enough evidence to determine the benefits and harms of laser-assisted cataract surgery compared with standard
ultrasound cataract surgery. The evidence is uncertain because current studies have not been large enough to provide a reliable answer
to this question.
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What was studied in the review?
As people become older, the lens inside the eye can become cloudy. This is known as a cataract, and it is the leading cause of blindness in
the world. Cataract surgery is one of the most commonly performed operations. During standard cataract surgery, the doctor removes
the cloudy lens material and places an artificial lens in the remaining bag or capsule. The aim of laser-assisted cataract surgery is to
provide more precise control over the steps involved in cataract surgery. This could make it easier to do the operation more reliably, and
faster, than if it is done in the standard way. This may result in fewer complications, such as tears to the person’s lens capsule, which in
turn could lead to better vision and quality of life for people who have had cataract surgery.
What are the main results of the review?
The review authors found 16 relevant studies. Most studies (13) were from Europe and three studies were from Brazil, India and China.
All these studies compared laser-assisted cataract surgery with standard ultrasound phacoemulsification cataract surgery for people with
cataracts. Eleven of the studies were either funded by the manufacturer of the laser machine or the investigators reported financial links
with the manufacturer.
The review authors were uncertain as to whether laser-assisted cataract surgery reduces the number of tears to the capsule because there
were very few cases of capsule tears in these studies. They judged this as very low certainty evidence.
Other complications were also infrequent for both laser-assisted and standard cataract surgery. The authors judged this as low certainty
evidence.
There may be little difference in vision after laser-assisted cataract surgery compared with standard cataract surgery (low certainty
evidence).
Laser-assisted cataract surgery and standard cataract surgery may require the same amount of theatre time (low certainty evidence).
None of the studies reported the effect of the operations on people’s quality of life.
How up-to-date is this review?
The review authors searched for studies that had been published up to 16 May 2016.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Laser-assisted cataract surgery versus standard ultrasound phacoemulsif icat ion cataract surgery
Patient or population: people with age-related cataract
Setting: eye hospital
Intervention: laser-assisted cataract surgery
Comparison: standard ultrasound phacoemulsif icat ion cataract surgery
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of eyes
(studies)
Certainty of the evidence
(GRADE)
Comments
Risk with standard ul-
trasound phacoemulsi-
fication
Risk with laser-as-
sisted cataract surgery
Intraoperat ive compli-
cat ions: anterior cap-
sule tear
Only 4 events, 2 in each group - 1076
(10 RCTs)
⊕©©©
Very low 1
Intraoperat ive compli-
cat ions: posterior cap-
sule tear
Only 1 event, in standard group - 1076
(10 RCTs)
⊕©©©
Very low 2
Corrected distance vi-
sual acuity assessed
with: logMAR acuity
chart (lower scores
= better vision, scale
f rom: -0.3 to 1.3) at
least six months af ter
surgery
The mean corrected
distance visual acuity
ranged f rom 0.038 to -
0.03 logMAR units
The mean corrected
distance visual acuity in
the intervent ion group
was 0.03 logMAR units
lower (better vision) (0.
05 lower to 0.00)
- 224
(3 RCTs)
⊕⊕©©
Low 3
Patient
reported outcome mea-
sures (PROMs) at least
one month af ter surgery
See comments Not reported
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Postoperat ive compli-
cat ions: cystoid macu-
lar oedema
20 per 1000 11 per 1000
(4 to 33)
OR 0.58 (0.20 to 1.68) 957
(9 RCTs)
⊕⊕©©
Low 3
Postoperat ive compli-
cat ions: elevated in-
traocular pressure (1
day to 1 week af ter
surgery)
13 per 1000 8 per 1000
(2 to 33)
OR 0.57 (0.11 to 2.86) 903
(8 RCTs)
⊕⊕©©
Low 3
Costs and resource
use: total durat ion of
procedure
The mean total durat ion
of procedure in the con-
trol group ranged f rom
6.04 to 10.5 minutes
The mean total durat ion
of procedure in the in-
tervent ion group was 0.
10 minutes more (0.02
fewer to 0.21 more)
- 274
(3 RCTs)
⊕⊕©©
Low 3
No information on costs
or other resources re-
ported.
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI). The risk in the comparison group was the median risk in the included trials.
CI: conf idence interval; OR: odds rat io
GRADE Working Group grades of evidence
High certainty: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate certainty: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low certainty: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low certainty: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded for: risk of bias (-1) because studies were poorly reported and largely judged to be at unclear or high risk of
bias; imprecision (-1) because very few events; inconsistency as ef fect est imates in the 3 trials report ing events were 0.33,
1.13 and 3.03.
2 Downgraded for: risk of bias (-1) and imprecision (-2) as only 1 event.
3 Downgraded for risk of bias (-1) and imprecision (-1) as ef fect est imate imprecise with 95% CIs including or close to null (no
ef fect).
5
L
a
se
r-a
ssiste
d
c
a
ta
ra
c
t
su
rg
e
r
y
v
e
rsu
s
sta
n
d
a
rd
u
ltra
so
u
n
d
p
h
a
c
o
e
m
u
lsifi
c
a
tio
n
c
a
ta
ra
c
t
su
rg
e
r
y
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
6
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
B A C K G R O U N D
Description of the condition
Age-related cataract is the leading cause of visual impairment
worldwide (Quigley 2006); and cataract surgery is the most com-
monly performed eye operation worldwide, with an estimated
19.5 million procedures carried out in 2011 (Lawless 2012). Pre-
ferred surgical techniques have changed dramatically over the past
half century, with associated improvements in outcomes and sa-
fety (Riaz 2006). With this increase in safety and improvements
in visual outcomes, lens extraction with intraocular lens implan-
tation is now increasingly performed for the treatment of other
conditions, including refractive error and angle closure glaucoma
(Friedman 2006; Packard 2005).
Description of the intervention
Lasers have been used in corneal surgery for over a decade. More
recently, femtosecond laser platforms that may accurately and re-
producibly perform key steps in cataract surgery, including corneal
incisions, capsulotomy and lens fragmentation, are now available.
The potential advantages of laser-assisted surgery are broad and
include greater safety and better visual outcomes through greater
precision and reproducibility. These systems are expensive at out-
set; however, the costs may be mitigated by a reduction in com-
plication rates, less repeat surgery and better patient outcomes.
How the intervention might work
Phacoemulsification (ultrasound) is a highly successful technique
first introduced over 40 years ago. It is the standard method of
cataract surgery today in higher income countries, with reported
rates of major complications (posterior capsule rupture or vitreous
loss) of 1.95% (95% confidence interval (CI) 1.89% to 2.02%);
and overall intraoperative complication rates of 4.2% (95%CI 4.1
to 4.3%) (Day 2015). It consists of a series of manual steps, in-
cluding corneal incision creation, capsulorhexis (circular opening
of the front of the cataract lens capsule), removal of the cataract
with ultrasound and placement of an intraocular lens into the cap-
sular bag. Each step is dependent on successful completion of the
preceding steps and, therefore, surgical ability is critical to visual
outcome.
Femtosecond lasers have revolutionised corneal surgery such as
for LASIK flap creation, and femtosecond laser cataract surgery
platforms are now available. These can automate over half of these
steps including creation of the corneal incisions (with or without
additional incision to reduce astigmatism), capsulotomy and lens
fragmentation, facilitating lens removal. The remaining steps are
removal of the fragmented crystalline lens and insertion of the
intraocular lens, which still have to be completed by hand. The
femtosecond laser platforms use photo-dissection to create tissue
planes accurate to 5µm in the anterior segment through the for-
mation of cavitation bubbles, and as the focused pulses are ul-
trashort (10−15 seconds), this is thought to almost eliminate any
collateral damage to surrounding tissues (Donaldson 2013). The
laser energy imparted to the eye, however should not be consid-
ered to be insignificant.
While the overall range of possible operative complications in ei-
ther laser-assisted or manual phacoemulsification surgery are sim-
ilar, rates would be expected to be lower in laser-assisted proce-
dures as laser completed steps should be more precise and more re-
producible than those completed by hand. Ultimately, this should
also translate to fewer complications and better patient outcomes.
There is increasing evidence to support an advantage for laser-
assisted procedures with more accurate capsulotomy positioning,
shape and size reported when compared to manual capsulorhexis
(Friedman 2011; Kránitz 2011; Nagy 2011). This is associated
with better intraocular lens centration (ensuring correct centring
of the lens) (Kránitz 2011; Kranitz 2012; Nagy 2011), and less
intraocular lens tilt with fewer internal higher order aberrations
(Kranitz 2012; Miháltz 2011). By using a laser to fragment the
crystalline lens, less phacoemulsification (ultrasound) energy is
subsequently required to complete its removal. Reductions in ef-
fective phacoemulsification time have been reported, with zero
phacoemulsification time being possible in 30% of operations in
a series by Abell 2013. This study also reported a 36% lower en-
dothelial cell loss in the laser-assisted procedures compared to the
manual phacoemulsification (Abell 2013).
Data on the surgical learning curve (Bali 2012; Roberts 2013a),
and complication rates in laser-assisted cataract surgery procedures
have been reported in large case-series (Roberts 2013a, Abell 2015;
Chee 2015), with the complication rates appearing favourable
when compared to those from large series of manual phacoemul-
sification (Roberts 2013a).
A recent large comparative case-series of more than 4000 eyes un-
dergoing cataract surgery (1852 eyes in a laser-assisted group versus
2228 eyes in a standard phacoemulsification group) reported that
both techniques appeared “equally safe” and that rates of signifi-
cant intraoperative complications were low (Abell 2015). A recent
case-series of 1105 eyes undergoing laser-assisted cataract surgery
reported a 0.81% anterior capsule tear rate and a 0.27% posterior
capsule tear rate (Chee 2015). Studies comparing postoperative
visual acuities and intraocular lens power calculation predictability
for laser-assisted surgery with manual phacoemulsification proce-
dures have shown inconsistent results with some reporting better
CDVA (Kranitz 2012), higher proportions of those achieving 20/
20 or betterUDVA (Chee 2015), and better intraocular lens power
predictability for laser-assisted surgery (Filkorn 2012), whilst oth-
ers have reported no difference in CDVA (Filkorn 2012; Lawless
2012;Miháltz 2011), UDVA (Lawless 2012;Miháltz 2011) or in-
traocular lens power predictability (Lawless 2012; Roberts 2013b).
6Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Why it is important to do this review
Laser-assisted lens surgery platforms are now increasingly be-
ing used for lens extraction and intraocular lens implantation.
There are currently five commercially available systems in Eu-
rope: Catalys™ (AbbottMedical Optics), LENSAR™(LENSAR
Inc), LenSx® (Alcon), VICTUS™ (Bausch & Lomb Inc) and the
Femto LDV Z8 (Ziemer). The aims of this review are to compare
effectiveness of laser-assisted cataract surgery with standard pha-
coemulsification cataract surgery and gather evidence from RCTs
on safety.
O B J E C T I V E S
To compare the effectiveness of laser-assisted cataract surgery with
standard phacoemulsification cataract surgery by gathering evi-
dence on safety from randomised controlled trials (RCTs).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all randomised controlled trials (RCTs) that met the
inclusion criteria.
Types of participants
We included all participants who were enrolled in the respective
RCT whereby either the participant or one of their eyes was ran-
domised to either laser-assisted cataract surgery or standard pha-
coemulsification and intraocular lens implantation. Participants
were adults (18 years old or more).
Types of interventions
We included all RCTs comparing laser-assisted cataract surgery to
standard ultrasound phacoemulsification, with implantation of a
posterior chamber intraocular lens in both techniques.
Types of outcome measures
Primary outcomes
The primary outcome was intraoperative complications in the
operated eye.
Secondary outcomes
The secondary outcomes for this review were the following.
• Distance visual acuity in the operated eye after initial
cataract surgery. We considered corrected distance visual acuity
(CDVA) and uncorrected distance visual acuity (UDVA)
separately. CDVA demonstrates intervention safety, whilst
UDVA demonstrates intervention efficacy (see How the
intervention might work above). We considered long-term data,
where reported.
• Patient reported outcome measures (PROMs) at least one
month after surgery. These include patient satisfaction and/or
vision-related quality of life as measured by any validated
questionnaire, such as the Catquest-9SF.
• Any postoperative or long-term complications reported
within one year of initial surgery. We anticipated these may be
reported as overall risk of any complication, or more specifically
such as cystoid macular oedema, elevated intraocular pressure,
corneal decompensation, retinal detachment and posterior
capsule opacification.
• Costs and resource use (e.g. total duration of procedure,
number of operating rooms/practitioners).
• Refractive outcomes, including deviation from the
predicted refractive outcome.
Search methods for identification of studies
Electronic searches
We searched CENTRAL (which contains the Cochrane Eyes
and Vision Trials Register) (2016, Issue 4), Ovid MEDLINE,
Ovid MEDLINE In-Process and Other Non-Indexed Cita-
tions, Ovid MEDLINE Daily, Ovid OLDMEDLINE (Jan-
uary 1946 to May 2016), EMBASE (January 1980 to May
2016), Latin American and Caribbean Health Sciences Litera-
ture Database (LILACS) (January 1982 to May 2016), the IS-
RCTN registry (www.isrctn.com/editAdvancedSearch), Clinical-
Trials.gov (www.clinicaltrials.gov), the World Health Organiza-
tion (WHO) International Clinical Trials Registry Platform (IC-
TRP) (www.who.int/ictrp/search/en) and the U.S. Food and
Drugs Administration (FDA) website (www.fda.gov). We did not
use any date or language restrictions in the electronic searches for
trials. We last searched the electronic databases on 10 May 2016.
See: Appendices for details of search strategies for CENTRAL
(Appendix 1), MEDLINE (Appendix 2), EMBASE (Appendix 3),
LILACS (Appendix 4), ISRCTN (Appendix 5), ClinicalTrials.gov
(Appendix 6), the ICTRP (Appendix 7) and the FDA website
(Appendix 8).
Searching other resources
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We searched the reference lists of included studies to identify any
additional trials. We did not handsearch conference proceedings
or journals for this review.
Data collection and analysis
Selection of studies
Two review authors (ACD, DMG) working independently re-
viewed the titles and abstracts from the electronic literature
searches. They removed duplicate records and obviously irrelevant
reports. They classified abstracts as ’exclude’, ’unsure’ or ’include’.
The full-text for abstracts classified as ’unsure’ by both review au-
thors were retrieved and reassessed for inclusion. They sought to
link together multiple reports of the same study. They planned to
deal with potential discrepancies on unclear studies by contacting
the trial authors for clarification and additional information, how-
ever this was not required. Studies labelled as ’exclude’ by both
review authors were excluded, and those labelled ’include’ were
assessed for methodological quality. We organised translation of
non-English language reports, as needed.
Data extraction and management
Two review authors (ACD, DMG) extracted data using a standard
form developed by Cochrane Eyes and Vision. We compared these
and resolved discrepancies by discussion. One author (ACD) en-
tered the data into Review Manager 5 (RevMan 2014), following
the guidelines set out in Chapter 7 of the Cochrane Handbook for
Systematic Reviews of Interventions and this was verified by a second
review author (DMG) (Higgins 2011a).
Assessment of risk of bias in included studies
Each review author independently assessed risk of bias in the in-
cluded studies using the recommended tool in Chapter 8 of the
CochraneHandbook for Systematic Reviews of Interventions (Higgins
2011b). We assessed studies for the following criteria: sequence
generation and allocation concealment (selection bias), masking
(blinding) of participants and personnel (performance bias) and
outcome assessors (detection bias), incomplete outcome data (at-
trition bias) and selective outcome reporting (reporting bias).
Selection bias
We considered adequacy of random sequence generation and allo-
cation concealment. Methods of sequence generation considered
to be at low risk of bias include referring to random number tables
or a list of random assignments generated by a computer. Meth-
ods at high risk of bias include sequence generation, for example,
by odd or even dates of birth. We assessed any method of alloca-
tion concealment (such as central randomisation, use of sequential
numbered, opaque, sealed envelopes) which meets or exceeds the
minimal criteria for judging concealment of allocation sequence
(as detailed in section 8.10 of the Cochrane Handbook for System-
atic Reviews of Interventions (Higgins 2011b)) at low risk of bias.
Methods such as using an open random allocation schedule may
allow participants or investigators to possibly foresee assignment,
thus introducing selection bias, and we judged such studies at high
risk of bias.
Performance and detection bias
We considered the masking of outcome assessors by study out-
comes or group of outcomes in the included studies. Masking of
surgeons and participants was not possible with the interventions
being examined. High risk of bias was defined as no masking, or
incomplete masking, where the outcome was considered likely to
be influenced by lack of masking; or if masking of the outcome as-
sessor was attempted, but likely that the masking could have been
broken, and the outcome measurement likely to be influenced by
a lack of masking.
Attrition bias
We examined formissing outcome data, rates of follow-up, reasons
for losses to follow-up and analysis by the principle of intention-to-
treat. This included whether follow-up rates for the laser-assisted
lens surgery and manual phacoemulsification arms were similar,
and whether there were missing data for the outcomes of interest.
We considered studies to be at low risk of bias if, for example,
there were no missing data or reasons for missing outcome data
were unlikely to be related to the outcomes.
Reporting bias
We investigated for selective reporting by comparing published
reports to the study protocol, when available. We considered a
study to be at low risk of bias if the outcomes of interest were
reported in the prespecified way in both the protocol and in the
published report. We considered the risk of bias to be high if, for
example, not all of the study’s prespecified primary outcomes were
reported.
The judgement for each criterionwas reported as ’satisfactory’ (low
risk of bias), ’unsatisfactory’ (high risk of bias) or ’unclear’ (insuf-
ficient information to assess). Review authors were not masked to
the report authors and trial results during the assessment, and any
disagreements between the review authors were resolved by dis-
cussion. We planned to contact the report authors for additional
information on issues that were unclear after reviewing the origi-
nal study report, however this was not required.
Measures of treatment effect
Our primary outcome was a dichotomous outcome (whether or
not the eye suffers a complication during surgery). We used the
8Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
odds ratio (OR) with 95% confidence intervals (CIs). For contin-
uous outcomes we used the mean difference (MD) between com-
parison groups with 95% CIs.
Unit of analysis issues
The main unit of analysis issue is how the studies dealt with both
eyes. There are three options: (i) people are randomised to inter-
vention/comparator and one eye per person enrolled in the trial;
(ii) people are randomised but both eyes are included and the same
intervention/comparator applied to both eyes (iii) one eye is ran-
domly allocated to intervention and the other eye to comparator
(within-person study). We documented which design was used.
We planned to record whether the study authors stated explicitly
why they opted for a particular design, how the study eye was
selected and, for within-person studies, how each eye was ran-
domised but in the event none of the included studies provided
this level of information. None of the studies including more than
one eye per person took this into account in the analysis; we have
analysed the data as reported.
Dealing with missing data
We originally planned to contact the original investigators where
any data in regard to prespecified trial outcomes were not reported
in the final publication, however this was not required (with the
exception of the trial by Schargus 2015 where we were provided
with the postoperative CDVA standard deviation values following
request). We have done an available case analysis - none of the
studies had performed any imputation.
Assessment of heterogeneity
We assessed for methodological and statistical heterogeneity by
careful review of the studies, examination of the forest plots of
results of the studies and by examining the I2 statistic (%) to assess
inconsistency between studies.
Assessment of reporting biases
We planned to investigate publication bias by examination of fun-
nel plots for signs of asymmetry. However, there were not suffi-
cient trials contributing data to the meta-analyses (fewer than 10)
to make this worthwhile.
Data synthesis
Weperformeddata analysis according toChapter 9 of theCochrane
Handbook for Systematic Reviews of Interventions (Deeks 2011).We
pooled data using a random-effects model, unless there were three
or fewer trials contributing to the analysis, in which case we used
a fixed-effect model.
Subgroup analysis and investigation of heterogeneity
To date there are five commercially available femtosecond laser
cataract surgery systems: Catalys™ (Abbott Medical Optics
Inc), LENSAR™ (LENSAR Inc), LenSx® (Alcon), VICTUS™
(Bausch & Lomb Inc) and the Femto LDV Z8 (Ziemer Oph-
thalmic Systems AG) and it is possible that outcomes may differ
between manufacturers. We therefore report the results detailing
the platformmanufacturer for each relevant study. Currently there
are not enough trials for a subgroup analysis.
Sensitivity analysis
We planned to conduct a sensitivity analysis excluding trials at
high risk of bias, but there were too few RCTs contributing data
for each analysis to enable us to do this.
’Summary of findings’ table
In a modification to our published protocol, we prepared a ’Sum-
mary of findings’ table presenting relative and absolute risks for
the outcomes listed below. One review author (JE) independently
assessed the overall certainty of the evidence for each outcome
using the GRADE classification system (GRADEpro 2015); this
was checked by the other review authors.
1. Intraoperative complications: anterior capsule tear.
2. Intraoperative complications: posterior capsule tear.
3. Corrected distance visual acuity (CDVA) at least one
month after surgery.
4. Patient reported outcome measures (PROMs) at least one
month after surgery
5. Postoperative complications: cystoid macular oedema.
6. Postoperative complications: elevated intraocular pressure.
7. Costs and resource use: total duration of procedure
R E S U L T S
Description of studies
Results of the search
The electronic searches yielded a total of 2208 references (Figure
1). The Cochrane Information Specialist removed 754 duplicate
records and we screened the remaining 1454 reports. We rejected
1414 records after reading the abstracts and obtained the full-text
reports of 40 references for further assessment. We identified 16
studies which met the inclusion criteria and excluded 13 studies,
see Characteristics of excluded studies for details. In addition, we
identified another 11 studies as ongoing or completed but with no
data currently available. When the review is next updated we will
check to see if these studies have published data and if so assess
them for inclusion in the review.
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Figure 1. Study flow diagram.
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Included studies
Below is a summary of the 16 studies included in this review.
Further details of these can be found in the Characteristics of
included studies tables.
Design
The studies by Conrad-Hengerer 2013, Conrad-Hengerer 2014,
Conrad-Hengerer 2015, Dick 2014 and Schargus 2015 were
within-person studies, where one eye of each participant hadman-
ual phacoemulsification and the other eye laser-assisted cataract
surgery. None of these studies did a paired analysis. We have used
the data as reported.
Filkorn 2012, Hida 2014, Kovacs 2014, Kranitz 2012,
Mastropasqua 2014a, Mastropasqua 2014b, Nagy 2011, Nagy
2014, Reddy 2013, Takacs 2012 and Yu 2015 were parallel group
RCTs. The majority of these trials included one eye per person.
In Nagy 2011 6% of enrolled participants had bilateral surgery
(111 eyes, 105 people) and in Yu 2015 50% of cases were bilateral
(54 eyes, 36 people). No adjustment was made for within-person
correlation in these studies. We have used the data as reported.
Participants
The within-person studies in Germany by Conrad-Hengerer
2013, Conrad-Hengerer 2014, Dick 2014, Schargus 2015 and
Conrad-Hengerer 2015 enrolled 75 participants (150 eyes), 104
participants (208 eyes), 53 participants (106 eyes), 37 participants
(74 eyes) and 100 participants (200 eyes), respectively.
For the parallel group RCTs, Reddy 2013 recruited a total of 131
participants (131 eyes) in India. In Hungary, Kranitz 2012 en-
rolled 45 participants (45 eyes), Filkorn 2012 134 participants
(134 eyes), Takacs 2012 76 participants (76 eyes), Nagy 2014 40
participants (40 eyes) and Kovacs 2014 79 participants (79 eyes).
Mastropasqua 2014a and Mastropasqua 2014b recruited 60 par-
ticipants (60 eyes), and 90 participants (90 eyes) in Italy, respec-
tively. Hida 2014 recruited 80 participants (80 eyes) in Brazil.
In two studies both eyes of some participants were reported: Yu
2015 recruited 36 participants (54 eyes) in China and Nagy 2011
enrolled 105 participants (111 eyes).
Interventions
All included studies compared laser-assisted cataract surgery
to standard ultrasound phacoemulsification cataract surgery.
Conrad-Hengerer 2013, Conrad-Hengerer 2014, Conrad-
Hengerer 2015, Dick 2014 and Schargus 2015 used the Catalys
laser platform (OptiMedica, AMO). Reddy 2013 used the VIC-
TUS™laser platform (Bausch&LombTechnolas). Filkorn 2012,
Hida 2014, Kovacs 2014, Kranitz 2012, Nagy 2011, Nagy 2014,
Mastropasqua 2014a, Mastropasqua 2014b and Takacs 2012 used
the LenSx platform (Alcon Laboratories, Inc., Fort Worth, TX).
Yu 2015 used the LensAR platform.
Outcomes
Outcomes for each study are reported separately below.
• Nagy 2011: Circularity and area of capsulotomy,
intraocular lens decentration.
• Kranitz 2012: Intraocular lens decentration and tilt,
refraction, uncorrected distance visual acuity (UDVA) and
corrected distance visual acuity (CDVA).
• Takacs 2012: Postoperative central corneal oedema,
endothelial cell count and endothelial cell function expressed by
volume stress index.
• Filkorn 2012: Manifest refraction spherical equivalent,
CDVA, mean absolute error, mean error, postoperative
keratometry.
• Conrad-Hengerer 2013: Primary outcome measures:
Corneal endothelial cell loss and corneal thickness at three
months. Additional data reported: effective phacoemulsification
time, mean irrigation fluid volume, mean surgical time,
intraoperative and postoperative complications.
• Reddy 2013: Primary outcome measure: effective
phacoemulsification time. Secondary outcome measures: mean
phacoemulsification energy, mean phacoemulsification time,
volume of balanced salt solution, subjective surgeon assessment
of ease of phacoemulsification. Additional data reported:
capsulotomy comparisons, intraocular lens decentration, safety
data including posterior capsule tear and iris damage. Follow-up
was limited to one day postoperatively.
• Conrad-Hengerer 2014: Primary outcome measures: laser
flare counts and changes in macular thickness and volume.
Secondary outcome measures: absolute and effective
phacoemulsification time, and intraoperative and postoperative
complications. Follow-up was six months postoperatively.
• Dick 2014: Primary outcome measures: capsular bag
diameters and intraindividual difference in millimetres.
Additional data reported: phacoemulsification energy used.
Follow-up was three months.
• Nagy 2014: Surgically induced astigmatism and corneal
higher order aberrations. Additional data reported: intraoperative
and postoperative complications. Follow-up was three months.
• Kovacs 2014: Subgroup analysis of previous RCT (no
further data on this given). Primary outcome measure:
quantification of posterior capsule opacification at 18-26 months
postoperatively. Additional data: intraocular lens tilt and
decentration.
• Mastropasqua 2014a: UDVA, CDVA, keratometric
astigmatism, corneal endothelial cell count, corneal thickness at
the incision site and higher order corneal aberrations. Follow-up
was six months.
• Mastropasqua 2014b: Stated aim to report capsulotomy
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features including circularity and size. Study also reports UDVA
and CDVA, subjective refraction data.
• Hida 2014: Capsulotomy size and shape parameters.
Additional data: intraoperative complications in the laser arm
(there is no description of the occurrence or non-occurrence of
complications in the manual phacoemulsification arm) and
refractive outcomes. The follow-up period is not described.
• Schargus 2015: Primary outcome: corneal endothelial cell
count measurements. Secondary outcomes: corneal thickness,
intraocular pressure, CDVA, overall surgery time and quantity of
fluid passing through the eye. Follow-up was six months.
• Conrad-Hengerer 2015: Primary outcome measures were
early and late CDVA and the deviation from the target refraction
using the spherical equivalent refraction. Secondary outcome
measures were anterior chamber depth and keratometry values.
• Yu 2015: Various outcome measures including average and
effective phacoemulsification time, total cataract surgery time,
capsulotomy size, corneal endothelial cell density, postoperative
refraction and CDVA.
Excluded studies
We excluded 13 studies and details of these are in the
Characteristics of excluded studies table.
Risk of bias in included studies
We assessed the included studies for possible biases, with findings
as below.
Allocation
See Figure 2; Figure 3.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias in each included study.
13Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Although all studies were described as randomised, there was vari-
able reporting as to the method of randomised sequence gener-
ation used. Kranitz 2012, Nagy 2014 and Filkorn 2012 report
randomisation was done using “computer-generated tables” or a
“computer randomization chart.” Nagy 2011 and Takacs 2012
used “computer randomization.” At best, Mastropasqua 2014b
state a “computer-generated, 6-block, 15-patient randomization
list was generated using an in-house closed-source software devel-
oped in MATLAB (MATLAB 2009). Patients were assigned to
1 of the 3 treatments with an equal probability for each group.”
Other studies did not describe the method of sequence generation
and were judged at unclear risk of bias.
The methods of allocation concealment were insufficiently or not
described in all but one study (Schargus 2015), in which: “The
enclosed assignments were inserted into sequentially numbered,
opaque, well sealed envelopes for allocation concealment, which
were continuously monitored. Investigators ensured that the en-
velopes were opened sequentially and only after the participant’s
name and other details were written on the appropriate envelope.”
We judged this study to be at low risk of allocation concealment
bias. The studies by Conrad-Hengerer 2013, Conrad-Hengerer
2014, Conrad-Hengerer 2015 and Dick 2014 used envelopes for
allocation concealment and “the surgeon opened the correspond-
ing envelope” at the time of surgery. As no further details about
the allocation concealment methodology were given (e.g. use of
sequentially numbered envelopes), we judged these studies to be
at unclear risk of bias. None of the other trials gave details on the
methods of allocation concealment used and we judged them to
be at unclear risk of bias.
Blinding
Surgeonmaskingwas not possible and in general participantmask-
ing was not described so most studies were judged to be high risk
for performance bias. In Mastropasqua 2014b “The patients were
masked to group assignment until the study was completed” however
it was unclear how the patients could remain masked unless sham
laser was performed, and there was no description of this, so we
judged this to be unclear risk of bias. Reddy 2013 was described
as open label and was considered to be definitely not masked and
judged to be at high risk of both performance and detection bias.
Masking of any outcome assessment was described in 6 stud-
ies. For the studies by Conrad-Hengerer 2013 and Dick 2014, a
masked technician performed the “full clinical examination” and
“all slit-lamp measurements” respectively, following surgery. In
Mastropasqua 2014b the “examiners performing preoperative and
postoperative assessments were masked to group assignment until
the study was completed.” In Takacs 2012, “examiners were not
aware of which surgical procedure had been used when perform-
ing the postoperative examinations.” In the study by Kovacs 2014,
masking of posterior capsule opacification measurement only is
described (study primary outcome).
For Yu 2015, capsulorhexis size only was measured by a masked
examiner but masking of other outcomes was not described.
No outcome assessment masking was described in the other in-
cluded studies.
Incomplete outcome data
There was variable reporting of data attrition with only eight of
the 16 included studies providing any detail.
In the study by Conrad-Hengerer 2013, 2/75 participants (4/150
eyes) were excluded at the three-month follow-up (one due to poor
health - cancer; and one had moved abroad). Conrad-Hengerer
2014 and Conrad-Hengerer 2015 state that 102/104, and 196/
200 eyes respectively, were included and analysed at six months
postoperatively. In the study by Dick 2014, “all patients were
included in the 3-month follow-up.” For Mastropasqua 2014a,
based on the number of eyes reported in figure 1, there was no
loss to follow-up. For Mastropasqua 2014b, based on the results
(“Each group comprised 30 eyes (30 patients)”), there was no loss
to follow-up. For Filkorn 2012, the number of patients at baseline
was the same as those with postoperative data. We assessed these
seven studies to be at low risk of bias.
A total of 14/131 participants were excluded in Reddy 2013. One
eye in the laser-assisted group was excluded from analysis because
of a protocol violation (no details of this are given). Seven eyes in
the laser-assisted group and four in the manual group were also
excluded from further analysis with the reason for this being de-
scribed as “to guarantee correct data analysis and rule out preop-
erative bias” by ensuring “equal cataract grade distributions in the
2 study groups” were present. We judged this study to be at high
risk of bias.
Selective reporting
All studies reported prespecified outcome measures in their
methodology, however, it was unclear whether these were truly
prespecified, as no study protocol was available and the trials were
not registered on a clinical trials’ database. It was unclear if the
statistical analysis methods were prespecified, and therefore, al-
though none of the included studies appeared to demonstrate se-
lective reporting, we judged all to be at unclear risk of bias.
Effects of interventions
See: Summary of findings for the main comparison
Laser-assisted cataract surgery versus standard ultrasound
phacoemulsification cataract surgery
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Intraoperative complications in the study eye
(primary outcome)
There was variable reporting of types and detail regarding intra-
operative complications between studies.
See Analysis 1.1
Anterior capsule tears
The number of anterior capsule tears reported in the included
studies was low. In Conrad-Hengerer 2013 there was one tear in
75 eyes in the control group and none in the laser group. In Reddy
2013 there was one anterior capsule tear in the laser group (out
of 56 eyes) and one in the control group (63 eyes). In Conrad-
Hengerer 2015 there was one in the laser group and none in the
standard phacoemulsification group.
We assume that in Nagy 2011, Kranitz 2012, Conrad-Hengerer
2014, Nagy 2014, Kovacs 2014 and Schargus 2015 there were
no anterior capsule tears in either arms, as they reported there
were either no intraoperative complications or described other
intraoperative complications, but did not specifically describe the
occurrence of any anterior capsular tear. Hida 2014 reported no
intraoperative complications in the laser-assisted arm, but did not
report any data on complications for the phacoemulsification arm.
In Filkorn 2012, Mastropasqua 2014a and Mastropasqua 2014b
complications were excluded and therefore not reported. Takacs
2012 and Dick 2014 did not provide data on complications. In
Yu 2015 there were no anterior capsule tears in either arm.
The estimates of the effect in the three studies contributing events
were different (0.33, 1.13, 3.03) and with very wide confidence
intervals (Analysis 1.1). We did not pool the data because an av-
erage of these three different estimates would be unlikely to be
informative.
We graded this evidence as very low certainty. We downgraded for
risk of bias, imprecision and inconsistency (Summary of findings
for the main comparison).
Posterior capsule tears
Schargus 2015 reported one posterior capsular tear (1/37 eyes)
in the standard phacoemulsification arm and none (0/37) in the
laser-assisted arm. In the trial by Yu 2015 there were no poste-
rior capsule tears in either arm. We assume that in Nagy 2011,
Kranitz 2012, Conrad-Hengerer 2014, Nagy 2014 and Kovacs
2014, there were no posterior capsule tears as they report there
were no intraoperative complications. For Conrad-Hengerer 2013
and Conrad-Hengerer 2015 occurrence of anterior capsule tears
are described and the other cases are described as “uneventful” or
“without further complications.” Reddy 2013 describes a range
of intraoperative complications and states in the discussion that
there were no posterior capsular tears in either group. In Filkorn
2012, Mastropasqua 2014a and Mastropasqua 2014b complica-
tions were excluded and therefore not reported. Hida 2014 re-
ported no intraoperative complications in the laser-assisted arm,
but did not report any data on complications for the phacoemul-
sification arm. Takacs 2012 and Dick 2014 did not provide data
on complications.
We graded the certainty of evidence as very low. We downgraded
one level for risk of bias and two levels for imprecision (Summary
of findings for the main comparison).
Distance visual acuity in the operated eye at least one
month after cataract surgery
Seven studies reported data on postoperative visual acuity. In
summary, Mastropasqua 2014a and Mastropasqua 2014b found
no statistically significant difference in uncorrected distance vi-
sual acuity (UDVA) or corrected distance visual acuity (CDVA)
between laser-assisted and standard phacoemulsification groups.
Filkorn 2012, Schargus 2015 and Yu 2015 found no statistically
significant difference in CDVA between laser-assisted and manual
phacoemulsification groups. Kranitz 2012 found no difference in
UDVA at one month or one year; however, CDVA was statistically
significantly better in the laser arm at both these time points.
Conrad-Hengerer 2015 reported that “themeanUDVA improved
faster in the femtosecond laser-assisted group than in the conven-
tional group. There was a statistically significant between-group
difference 2 hours, 3 days, and 1 week postoperatively (P < 0.05).
Beginning from 1month on, no statistically significant differences
were detected.” No further comparisons on postoperative visual
acuities were made.
Corrected distance visual acuity
In Kranitz 2012, CDVA was 0.89 decimal Snellen (standard de-
viation (SD) 0.17) and 0.77 decimal Snellen (SD 0.25) in laser-
assisted and standard phacoemulsification arms, respectively, at
one week postoperatively (P > 0.05). One month postoperatively,
CDVA was 0.94 decimal Snellen (SD 0.11) and 0.84 decimal
Snellen (SD 0.16) in laser-assisted and standard phacoemulsifica-
tion arms, respectively (P = 0.031). At one year postoperatively,
CDVA values were 0.97 decimal Snellen (SD 0.06) and 0.92 dec-
imal Snellen (SD 0.09) laser-assisted and manual phacoemulsifi-
cation arms, respectively (P = 0.038).
In Filkorn 2012, CDVA was 0.03 (SD 0.06) logMAR and 0.02
(SD 0.04) logMAR laser-assisted and standard phacoemulsifica-
tion arms, respectively, at mean 10 weeks postoperatively.
In Mastropasqua 2014a, CDVA was 0.18 (SD 0.18) logMAR
and 0.16 (0.12) logMAR laser-assisted and standard phacoemul-
sification arms, respectively, at one month postoperatively. At six
months postoperatively, CDVA values were -0.08 (0.09) and -
0.03 (0.12) logMAR laser-assisted and manual phacoemulsifica-
tion arms, respectively. They found no statistically significant dif-
ference between study arms for CDVA at either time point.
In Mastropasqua 2014b, mean CDVA at one week was -0.03 (SD
0.05) and -0.03 (0.14) in laser groups 1 and 2, respectively, com-
pared to 0.01 (0.07) in the standard phacoemulsification group.
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Mean CDVA at one month was -0.08 (0.05) and -0.09 (0.12) in
laser groups 1 and 2, respectively, compared to -0.06 (0.10) in
the standard phacoemulsification arm.Mean CDVA at six months
was -0.09 (0.12) and -0.08 (0.05) in laser groups 1 and 2, respec-
tively, compared to -0.06 (0.10) in the standard phacoemulsifi-
cation arm. They found no statistically significant difference be-
tween arms at any time point.
In Schargus 2015, CDVA was reported as 0.049 logMAR at three
months and 0.024 logMAR at six months in the laser-assisted
arm. In the manual phacoemulsification arm, CDVA was 0.057
logMAR at three months and 0.038 logMAR at six months. They
found no statistically significant difference between the two groups
(P = 0.46).
In Yu 2015, CDVA at one day postoperatively was 0.16 (0.20)
logMAR and 0.35 (0.45) logMAR in the laser and manual pha-
coemulsification arms, respectively. At one week postoperatively,
the CDVA was 0.06 (0.15) logMAR and 0.18 (0.21) logMAR in
the laser and manual phacoemulsification arms, respectively. At
one month, CDVA was 0.09 (0.10) logMAR and 0.19 (0.44) log-
MAR in the laser and manual phacoemulsification arms, respec-
tively. At three months, CDVA was 0.12 (0.09) logMAR and 0.33
(0.56) logMAR in laser and manual phacoemulsification arms, re-
spectively.
CDVA data fromKranitz 2012 was not included in themeta-anal-
ysis due to visual acuity data being reported in Snellen rather than
logMAR. Whilst conversion of mean Snellen values to logMAR is
possible, conversion of SDs is not.
As seen inAnalysis 1.2, therewere nodifferences in eitherCDVAor
UDVA between arms with the exception of CDVA at six months.
Here we found some evidence to support a very small advantage
for the laser-assisted arm (MD -0.03 logMAR, 95% CI -0.05 to
-0.00; eyes = 224). This difference is equivalent to 1.5 logMAR
letters between groups and is not thought to be of any clinical
significance.
Overall, we graded the certainty of visual acuity evidence as low.
We downgraded for risk of bias and imprecision (Summary of
findings for the main comparison).
Uncorrected distance visual acuity
Kranitz 2012, Mastropasqua 2014a, Mastropasqua 2014b and
Conrad-Hengerer 2015 report data on UDVA outcomes.
In Kranitz 2012, UDVA at one week was 0.59 decimal Snellen
(SD 0.23) and 0.51 decimal Snellen (SD 0.29) laser-assisted and
standard phacoemulsification arms, respectively. At one month,
UDVA values were 0.69 decimal Snellen (SD 0.19) laser-assisted
versus 0.61 decimal Snellen (SD 0.28) standard phacoemulsifica-
tion. At one year, UDVA values were 0.63 decimal Snellen (SD
0.23) laser-assisted versus 0.60 decimal Snellen (SD 0.25) in the
standard phacoemulsification arm. They found no statistically sig-
nificant difference between arms at any time point.
In Mastropasqua 2014a, UDVA at one month postoperatively
was 0.35 (0.23) logMAR in the laser arm and 0.28 (0.13) in the
standard phacoemulsification arm. At six months postoperatively,
meanUDVAwas 0.13 (0.21) and 0.08 (0.15) logMAR in the laser-
assisted and standard phacoemulsification arms, respectively. No
statistically significant difference in UDVA values between arms
were found.
InMastropasqua 2014b,meanUDVA at oneweekwas 0.08 (0.08)
logMAR in laser arm 1, 0.07 (0.09) in laser arm 2 and 0.18 (0.05)
in the standard phacoemulsification group. At one month, mean
UDVAs were 0.10 (0.10), 0.09 (0.13) and 0.21 (0.09), laser arms
1 & 2, and standard phacoemulsification arm, respectively. At
six months postoperatively, mean UDVAs were 0.09 (0.08), 0.10
(0.05) and 0.25 (0.05), laser arms 1&2, and standard phacoemul-
sification arm, respectively. They found no statistically significant
difference between arms at any time point.
Conrad-Hengerer 2015 found early differences inUDVA between
arms, however no differences were found after one month with up
to six months follow-up. No details on postoperative visual acuity
values were given.
Patient reported outcome measures (PROMs) at
least one month after cataract surgery
No data on patient-reported outcome measures were reported by
any of the 16 included studies.
Postoperative or long-term complications reported
within one year of cataract surgery
Cystoid macular oedema
Four studies reported cystoid macular oedema (Conrad-Hengerer
2013; Conrad-Hengerer 2014; Conrad-Hengerer 2015; Schargus
2015). Two out of 73 eyes (Conrad-Hengerer 2013), 2/104
(Conrad-Hengerer 2014), 0/37 (Schargus 2015) and 1/100
(Conrad-Hengerer 2015) in the laser groups developed postop-
erative cystoid macular oedema compared to 3/73, 3/104, 1/37
and 2/100 eyes in the manual phacoemulsification arms, respec-
tively. In the studies by Nagy 2011, Kranitz 2012, Nagy 2014 and
Kovacs 2014 it is stated that there were no postoperative compli-
cations and thus we assume there were no cases of cystoid mac-
ular oedema. In Mastropasqua 2014a and Mastropasqua 2014b
complications were excluded, and therefore not reported. Filkorn
2012, Takacs 2012, Dick 2014 and Hida 2014 did not provide
data on complications. Yu 2015 provides some information on
raised postoperative intraocular pressure, but does not specifically
mention any cases of cystoid macular oedema following surgery,
and so we assume there were no cases.
Overall, this gives: odds ratio (OR) 0.58, 95% CI 0.20 to 1.68;
eyes = 957, studies = 9 (Analysis 1.4). We graded this as low
certainty evidence.Wedowngraded for risk of bias and imprecision
(Summary of findings for the main comparison).
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Raised intraocular pressure
Five studies specifically reported intraocular pressure in the post-
operative period and 4 of these gave data at specified time
points (Conrad-Hengerer 2013;Conrad-Hengerer 2014;Conrad-
Hengerer 2015; Schargus 2015). The study by Yu 2015 does not
give the time point at which the raised IOP was identified. In the
study by Schargus 2015, it must be noted that no ophthalmic vis-
cosurgical device was used in the laser arm, but was in the standard
phacoemulsification arm. Additionally those in the standard pha-
coemulsification arm were given oral acetazolamide for intraocu-
lar pressure prophylaxis, whilst those in the laser arm were not.
Follow-up in the study by Reddy 2013 was limited to one day and
“no adverse events were observed.” In the studies by Nagy 2011,
Kranitz 2012, Nagy 2014 and Kovacs 2014, it is stated that there
were no postoperative complications, and thus it is assumed there
were no cases of elevated intraocular pressure. In Mastropasqua
2014a andMastropasqua 2014b, complicationswere excluded and
therefore not reported. Filkorn 2012, Takacs 2012, Dick 2014
and Hida 2014 did not provide data on complications.
Considering elevated intraocular pressure immediately after
surgery, the number of events was low: 2/75, 1/104, 0/37
and 3/100 eyes in the laser arms of Conrad-Hengerer 2013,
Conrad-Hengerer 2014, Schargus 2015 and Conrad-Hengerer
2015 respectively; compared to 2/75, 2/104, 1/37 and 2/100 for
the standard phacoemulsification arms: OR 0.88, 95% CI 0.29
to 2.66; eyes = 1022, studies = 9) (Analysis 1.4).
Considering elevated intraocular pressure reported between one
day and one week postoperatively, the number of events was
low: 1/75, 0/104, 1/37 and 0/100 eyes in the laser arms of
Conrad-Hengerer 2013, Conrad-Hengerer 2014, Schargus 2015
and Conrad-Hengerer 2015, respectively; compared to 0/75, 1/
104, 3/37 and 0/100 for the standard phacoemulsification arms:
OR 0.57, 95% CI 0.11 to 2.86; eyes = 903, studies = 8; I2 = 0%
(Analysis 1.4). Yu 2015 reported one eye (1/29) in the manual
phacoemulsification arm had steroid response ocular hyperten-
sion, and none (0/25) in the laser arm. They do not describe the
time after surgery at which this occurred and so this data has not
been included in Analysis 1.4.
We judged the evidence for postoperative complications to be of
low certainty and downgraded for risk of bias and imprecision
(Summary of findings for the main comparison).
Posterior capsule opacification
Only Kovacs 2014 and Yu 2015 reported posterior capsule opaci-
fication rates. In Yu 2015, 2/29 eyes in the control required YAG
laser posterior capsulotomy at one and three months, respectively,
following surgery. No eyes (0/25) in the laser arm required YAG
capsulotomy.
Kovacs 2014 investigated posterior capsule opacification develop-
ment between arms for between 18-26 months postoperatively.
They found higher posterior capsule opacification scores in the
standard phacoemulsification arm, however, no patients in either
arm required YAG laser posterior capsulotomy (0/39 standard
phacoemulsification arm, 0/40 laser-assisted arm).
Other complications
No study specifically mentioned any cases of postoperative corneal
decompensation or retinal detachment, and thus we assume none
occurred.
Costs and resource use
No data on costs were reported by any of the 16 included studies.
Three studies reported data on the duration of the procedure
(Analysis 1.3). There was little evidence for a difference between
the procedures: mean difference (MD) 0.10 minutes, (95% CI -
0.02 to 0.21; eyes = 274, studies = 3). (Summary of findings for
the main comparison). One additional study (Conrad-Hengerer
2014) did report procedure durations, but did state there was no
significant difference in surgery times between arms.
Refractive outcomes
Five studies reported data on refractive outcomes (Filkorn 2012,
Hida 2014,Mastropasqua 2014b, Yu 2015 and Conrad-Hengerer
2015). There were differences in how the refractive results were
reported between studies which limited comparisons between trial
arm.
Filkorn 2012 reported the achieved postoperative spherical equiv-
alents were -0.50 diopters (D) (SD 1.06) and -0.58 D (1.28) for
laser-assisted and standard phacoemulsification arms, respectively.
Mean errors were -0.03 D (0.47) and 0.07 D (0.63) laser-assisted
and standard phacoemulsification arms, respectively. Mean abso-
lute errors (MAE, mean of the individual prediction errors with-
out regard for its sign) were 0.38 D (0.28) and 0.50 D (0.38)
for laser-assisted and standard phacoemulsifications arms, respec-
tively. They found the MAE to be significantly lower in the laser-
assisted arm (P = 0.04), otherwise they found no significant dif-
ferences between arms. 42% eyes were within ±0.25D of target
refraction in the laser arm compared to 28% in the standard pha-
coemulsification arm. 69% eyes were within ±0.50D of target re-
fraction in the laser arm compared to 65% in the standard pha-
coemulsification arm. 99% eyes were within ±1.0D of target re-
fraction in the laser arm compared to 88% in the standard pha-
coemulsification arm. These data were “measured 6 to 12 weeks
after surgery.”
Hida 2014 reported the mean predicted and achieved postoper-
ative spherical equivalents were -0.30 D (SD 0.39) and -0.16 D
(0.38) for the laser-assisted arm. For the manual phacoemulsifica-
tion arm these were +0.33 D (SD 0.33) and -0.03 D (0.28). They
found no statistically significant differences between arms. Data
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on mean absolute errors were not reported, or proportions within
±0.50 or ±1.0 diopters target refraction were not reported.
Mastropasqua 2014b report data on postoperative refractive out-
comes and found the mean postoperative spherical equivalents at
one month to be -0.25D (0.38), -0.23 (0.64) and -0.39 (0.33)
in laser arms 1 and 2, and the standard phacoemulsification arm,
respectively. The mean postoperative spherical equivalents at six
months were -0.25D (0.54), -0.26 (0.40) and -0.41 (0.39) in laser
arms 1 and 2, and the standard phacoemulsification arm, respec-
tively. Mean absolute errors were 0.42 (0.16), 0.36 (0.36) and
0.54 (0.43) in laser arms 1 and 2, and standard phacoemulsifica-
tion arm, respectively at one month. Mean absolute errors were
0.44 (0.31), 0.43 (0.10) and 0.56 (0.39) in laser arms 1 and 2,
and standard phacoemulsification arm, respectively at six months.
They found statistically significant differences between groups for
postoperative spherical equivalent and mean absolute error. Pro-
portions within ±0.50 or ±1.0 diopters target refraction were not
reported.
Conrad-Hengerer 2015 reported the postoperative spherical
equivalents by various time points. At one month, postoperative
spherical equivalent was -0.05 D (0.28) in the laser arm versus -
0.18 D (0.54) in the manual phacoemulsification arm, and at six
months -0.05 D (0.28) versus -0.11 D (0.55), respectively. Ninety
eyes (92%) in the femtosecond laser-assisted group and 70 eyes
(71%) in the conventional group were within ±0.50 D of the tar-
get refractive outcome and 98 eyes (100%) in both groups were
within ±1.00 D at 6 months postoperatively. Data on mean abso-
lute errors were not reported.
Yu 2015 reported the absolute deviation between the attempted
and achieved spherical equivalents at one day, one week, one
month and three months postoperatively. They found no signifi-
cant difference except at three months postoperatively, where the
absolute deviation was statistically significantly lower in the laser
arm compared to the manual phacoemulsification arm (0.16 D
(0.16), versus 0.74 (0.65) P = 0.00, laser versus manual pha-
coemulsification, respectively). Proportions within ±0.50 or ±1.0
diopters target refraction were not reported.
The definition in Yu 2015 for “absolute deviation between the
attempted and achieved spherical equivalent” was consistent with
that for “mean absolute error” in the studies by Filkorn 2012 and
Mastropasqua 2014b, and so these studies were used for Analysis
1.5. Only data from the longest follow-up time point were used
for the analysis. We found some evidence for a difference in MAE
between the procedures: mean difference (MD) -0.18D for the
laser arm (95% CI: -0.27 to -0.09), eyes = 278, studies = 3). We
judged the evidence for postoperative refractive predictability to be
of low certainty. We downgraded for imprecision (the confidence
intervals include a clinically insignificant effect) and inconsistency
(I2=83%).
D I S C U S S I O N
Summary of main results
We found 16 small randomised studies meeting the inclusion cri-
teria. Reporting was variable on the types of intraoperative and
postoperative complications. Ten of 16 trials reported data on in-
traoperative complications, in six of these trials, there were either
no anterior or posterior capsule tears. In the four trials in which
these complications occurred, there were few events and there was
only one trial where posterior capsular rupture occurred (one eye,
standard phacoemulsification arm).
Only seven studies reported data on overall postoperative visual
acuity outcomes, of which data from five were sufficient to com-
bine for analyses. We found little evidence of any important dif-
ference in postoperative visual acuity between laser-assisted and
standard phacoemulsification arms. There was a small advantage
for the laser-assisted arm at six months in corrected distance visual
acuity that just met statistical significance. However, the difference
was equivalent to 1.5 logMAR letters and we considered this to be
clinically insignificant. There was a small difference in postopera-
tive refraction prediction error (mean absolute error) in favour of
laser-assisted surgery but the confidence intervals for this estimate
included a clinically insignificant effect.
None of the trials were powered to investigate for differences in
complication rates or postoperative visual acuity outcomes be-
tween arms or reported data on patient-reported outcome mea-
sures (visual function questionnaires) or cost-effectiveness. Fur-
ther appropriately powered randomised controlled trials (RCTs)
are recommended to address these issues.
Overall completeness and applicability of
evidence
Of the 16 RCTs thatmet the inclusion criteria, none reported data
for every outcome measure. Data on anterior or posterior capsule
tears were reported by 10 of the 16 included trials, however only
three reported usable data on visual outcomes with at least six
months follow-up. No studies reported data on visual function,
measured by patient-reported outcome measures, or data on cost-
effectiveness.
Certainty of the evidence
Overall, we graded the certainty of the evidence to be low or very
low. We downgraded for risk of bias because the trials were poorly
reported, and largely it was unclear as to the extent to which bias
had been avoided; we judged most trials to be at high risk of
performance bias and one trial to be at high risk of performance,
detection and attrition bias. The investigators in at least 11 trials
had financial links with the manufacturers of the laser platforms.
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None of the trials were prospectively registered and most of the
trials were published by two research groups; it was not always
possible to tell whether patients were double-counted, although
the investigators assured us that this was not the case.
We downgraded for imprecision because the trials were small and
complications occurred rarely, so the estimates of effect from the
pooled results were imprecise. In some cases the results of different
studies were inconsistent.
Potential biases in the review process
We had hoped to explore whether or not the differences in trial
designs, namely unilateral versus bilateral (paired-eye studies) im-
pacted on results. Whilst we found both paired and unpaired stud-
ies in our review, the paired studies had been analysed as unpaired.
Analysis ignoring this pairing lowers the chance of detecting a sig-
nificant difference between groups, but data was not presented in
a way that allowed us to explore this.
Femtosecond laser-assisted cataract surgery is a rapidly developing
area, and although we re-ran searches during the review to ensure
they were up-to-date, it is possible that a recently published study
may have been missed.
Agreements and disagreements with other
studies or reviews
A number of large case series have been published reporting out-
comes of laser assisted cataract surgery. Anterior capsular tear rates
range from 0.08% to 1.84%, (Roberts 2013a, Day 2014, Chee
2015, Abell 2015, Roberts 2015) and posterior capsular tear rates
from 0.27 to 0.43%.(Chee 2015, Abell 2015, Roberts 2013a) In
a prospective consecutive comparative case-series of 1852 laser-
assisted and 2228 control cases (Abell 2015); the rates of signif-
icant intraoperative complications were low in both groups, and
both techniques were thought to be equally safe, although ante-
rior capsule tear rates were statistically significantly higher in laser-
assisted cases (1.84% versus 0.22% in the standard phacoemulsi-
fication arm, P < 0.001). Chee 2015 compared visual outcomes in
a non-randomised case-series of 794 laser cataract operations with
420 matched manual phacoemulsification controls. They found
the proportion with a postoperative UDVA of 20/25 or better to
be significantly higher in the laser cases (68.6% vs 56.3%; P <
0.0001), and a non-significant trend towards lower MAE in the
laser cataract surgery cases was found (0.30D, SD 0.25D laser vs
0.33D, SD 0.25D controls, P = 0.062). A recent comparative case
series by Ewe 2016 found no clinically meaningful difference in
visual outcomes between 988 laser assisted cataract surgery and
888 manual phacoemulsification cataract surgery cases (laser post-
operative CDVA 0.09 logMAR (SD 0.13) vs standard phacoemul-
sification 0.12 logMAR (SD 0.22), P = 0.001), and also a high
MAE in laser assisted cases (0.41D vs 0.35 D; P < 0.0011).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence from the 16 randomised controlled trials (RCTs)
included in this review could not determine the equivalence or
superiority of laser-assisted cataract surgery compared to standard
manual phacoemulsification for our chosen outcomes due to the
low to very low certainty of the evidence available from these
studies.
Implications for research
As complications occur rarely, large adequately powered, well de-
signed, independent RCTs comparing the safety and efficacy of
laser-assisted cataract surgery with standard phacoemulsification
cataract surgery are needed. Standardised reporting of intraoper-
ative and postoperative complications, visual and refractive out-
comes for cataract surgery would facilitate future synthesis of tri-
als. Data on patient-reported outcomes and cost-effectiveness are
needed. Unit of analysis issues must be considered when conduct-
ing ophthalmic RCTs.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Conrad-Hengerer 2013
Methods Within-person (paired-eye) RCT
Participants Number of participants randomised: 75
Number of eyes included: 150
Country: Germany
Average age: 71 years
Sex: 63% female
Ethnic group: not described
Inclusion criteria: “All patients enrolled had a visually significant cataract, dilated pupil
width of 6.0 mm or larger, and were willing to volunteer for the trial after giving informed
consent”
Exclusion criteria: “The exclusion criteria included a history of serious coexisting ocular
disease, uncontrolled glaucoma, optic atrophy or ocular tumors, use of topical or systemic
steroids or nonsteroidal anti-inflammatory drugs (NSAIDs) during the previous 3 months,
relevant corneal opacities, poorly dilating pupils (pupil% 6.0 mm), known zonular weakness,
age less than 22 years, or participation in another clinical study”
Interventions Laser-assisted cataract surgery using theCatalys platform (Catalys Precision Laser System,
AMO) ormanual phacoemulsification using a Stellaris phacomachine (Bausch&Lomb)
Outcomes Primary outcome measures: Corneal endothelial cell loss and corneal thickness at up to
3 months. Additional data reported: effective phacoemulsification time, mean irrigation
fluid volume, mean surgical time, intraoperative and postoperative complications
Notes Funding source: not reported
Declaration of interest: “Dr. Dick is a member of the medical advisory board of OptiMedica
Corp”
Date study conducted: February 2012 to July 2012
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Themethod of sequence generation is not described
Allocation concealment (selection bias) Unclear risk “the surgeon opened the corresponding envelope, receiv-
ing information about the procedure to use in each eye;
that is, femtosecond laser - assisted or standard pha-
coemulsification”
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Conrad-Hengerer 2013 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible; no efforts to mask
participants are described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “All patients had a full clinical examination by the
same masked trained technician”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Two patients were excluded at the 3-month follow-up
because they missed their previous visits. One patient
had cancer and was not available for further visits; the
other moved to another county”
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry
(trial was not registered)
Conrad-Hengerer 2014
Methods Within-person (paired-eye) RCT
Participants Number of participants randomised: 104
Number of eyes included: 208
Country: Germany
Average age: 71 years
Sex: 56% female
Ethnic group: not described
Inclusion criteria: only the exclusion criteria below are given
Exclusion criteria: “history of coexistent ocular disease (eg, glaucoma, high myopia, retinal
diseases affecting the macula, optic atrophy, or ocular tumors), use of topical or systemic
steroids or nonsteroidal anti-inflammatory drugs during the prior 3 months, relevant corneal
opacities, age younger than 22 years, or participation in another clinical study”
Interventions Laser-assisted cataract surgery using theCatalys platform (Catalys Precision Laser System,
AMO) ormanual phacoemulsification using a Stellaris phacomachine (Bausch&Lomb)
Outcomes Primary outcome measures: laser flare counts and changes in macular thickness and
volume. Secondary outcome measures: absolute and effective phacoemulsification time;
and intraoperative and postoperative complications. Follow-up was 6 months postoper-
atively
Notes Funding source: not reported.
Declaration of interest: “Dr. Dick was a member of the medical advisory board of Opti-
Medica. The remaining authors have no financial or proprietary interest in the materials
presented herein”
Date study conducted: March 2012 to October 2012
Trial registration number: not reported
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Conrad-Hengerer 2014 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Themethod of sequence generation is not described
Allocation concealment (selection bias) Unclear risk “After positioning the patient on the operating bed, the
surgeon opened the corresponding envelope indicating
which procedure to choose (ie, femtosecond laser-as-
sisted or standard phacoemulsification)”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible, no efforts to mask
participants are described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Nomasking of the outcome assessment is described
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Two hundred two eyes (97%) were included and an-
alyzed at 6 months postoperatively.” No further infor-
mation is given
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry
(trial was not registered)
Conrad-Hengerer 2015
Methods Within-person (paired-eye) RCT
Participants Number of participants randomised: 100
Number of eyes included: 200
Country: Germany
Average age: 72 years
Sex: 56% female
Ethnic group: not described
Inclusion criteria: “a potential corrected visual acuity of 0.8 (20/25) in both eyes”
Exclusion criteria: “amblyopia, a history of serious coexistent ocular disease (eg, pseudoexfoli-
ation, uncontrolled glaucoma, macular pathologies, high myopia, or hyperopia, defined as an
axial length [AL] < 21.5 mm or > 27.5 mm), corneal astigmatism of more than 1.5 diopters
(D), optic atrophy, ocular tumors, use of topical or systemic steroids or nonsteroidal anti-
inflammatory drugs during the previous 3 months, relevant corneal opacities, Fuchs dystrophy,
cornea guttata, an age younger than 22 years, and participation in another clinical study.
Furthermore, a dilated pupil of at least 6.0 mm preoperatively was necessary”
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Conrad-Hengerer 2015 (Continued)
Interventions Laser-assisted cataract surgery using the Catalys platform to produce capsulotomy and
lens fragmentation; or manual phacoemulsification cataract surgery
Outcomes “Primary outcome measures were early and late corrected distance visual acuity (CDVA)
and the deviation from the target refraction using the spherical equivalent (SE) refraction.
Secondary outcome measures were anterior chamber depth (ACD) and keratometry values”
Notes Funding source: not reported
Declaration of interest: “Dr. Dick is a member of the medical advisory board of Abbott
Medical Optics, Inc. No other author has a financial or proprietary interest in any material
or method mentioned”
Date study conducted: not reported
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Themethod of sequence generation is not described
Allocation concealment (selection bias) Unclear risk “After placing the patient on the laser system’s operat-
ing bed, the surgeon opened the corresponding envelope
providing the information about which procedure to
use; that is, femtosecond laser-assisted cataract surgery
or regular phacoemulsification”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible; no efforts to mask
participants are described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Nomasking of the outcome assessment is described
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Six months postoperatively, 196 eyes were included
and analyzed.” No further details are given
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry
(trial was not registered)
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Dick 2014
Methods Within-person (paired-eye) RCT
Participants Number of participants randomised: 53
Number of eyes included: 106
Country: Germany
Average age: 71 years old
Sex: 57% female
Ethnic group: not described
Inclusion criteria: “a visually significant cataract (corrected distance visual acuity < 20/
25) in both eyes, dilated pupil width of 6.0 mm or greater, and were willing to volunteer
for the trial after giving an informed consent ”
Exclusion criteria: “included corneal scars, corneal diseases, corneal astigmatism of 1.
5 diopters or greater, reduced endothelial cells, glaucoma, pseudoexfoliation syndrome,
zonular weakness, single eye, malformations, history of ocular surgery, intraocular tu-
mours, active or past inflammations, age-relatedmacular degeneration, diabetic retinopa-
thy, axial length difference (greater than 0.5 mm and less than 21.5 mm or greater than
26 mm), pregnancy, reduced compliance, age younger than 22 years, or participation in
another clinical study ”
Interventions Laser-assisted cataract surgery using theCatalys platform (Catalys Precision Laser System,
AMO) ormanual phacoemulsification using a Stellaris phacomachine (Bausch&Lomb)
Outcomes Primary outcome measures: absolute capsular bag diameters and intraindividual differ-
ence in milliammeters. Additional data reported: phacoemulsification energy used. Fol-
low-up was 3 months
Notes Funding source: not reported
Declaration of interest: “The authors have no financial or proprietary interest in thematerials
presented herein”
Date study conducted: not reported
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Themethod of sequence generation is not described
Allocation concealment (selection bias) Unclear risk “For randomization, the patient was placed on the op-
erating bed of the laser system and a corresponding en-
velope with the information about the receiving proce-
dure was opened by the surgeon”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study
methodology described
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Dick 2014 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “All slit-lamp measurements were done by a single
trained technicianwhowas blinded to the surgical tech-
nique”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All patients were included in the 3 month follow-
up
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry
(trial was not registered)
Filkorn 2012
Methods Parallel-group RCT
Participants Number of participants randomised: 134 (77 laser arm, 57 control arm)
Number of eyes included: 134 (77 laser arm, 57 control arm)
Country: Hungary
Average age: 65 years laser arm, 64 years control arm
Ethnic group: not described
Inclusion criteria: not described
Inclusion criteria: previous ocular surgery, corneal diseases such as keratoconus, known
zonular weakness, corneal astigmatism 3.00 D, anterior capsule tear, posterior capsule
rupture, severe macular disease, and amblyopia
Interventions Surgical intervention: Laser-assisted cataract surgery using the LenSx (AlconLaboratories
Inc) or manual phacoemulsification (Accurus, Alcon Laboratories Inc)
Outcomes Intraocular lens power calculation, visual and refractive outcomes
Notes Funding source: not reported
Declaration of interest: “Drs Knorz and Nagy are consultants to Alcon LenSx Inc. All
remaining authors have no financial interest in the materials presented herein”
Date study conducted: not reported
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patients were randomly assigned to each group using a computer
randomisation chart
Allocation concealment (selection bias) Unclear risk The method of allocation concealment is not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study methodology de-
scribed. No masking of participants is described
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Filkorn 2012 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No masking of the outcome assessment is described
Incomplete outcome data (attrition bias)
All outcomes
Low risk Based on the number of patients/eyes reported in figure 2, there
was no loss to follow-up
Selective reporting (reporting bias) Unclear risk “Patients withCDVA20/40 or worse were excluded (one patient
in each group) to avoid errors in manifest refraction”
No access to study protocol or trials registry entry (trial was not
registered)
Hida 2014
Methods Parallel-group RCT
Participants Number of participants randomised: 80 (40 laser arm, 40 control arm)
Number of eyes included: 80 (40 laser arm, 40 control arm)
Country: Brazil
Average age: 67 years laser arm, 65 years control arm
Ethnic group: not described
Inclusion criteria: not described
Exclusion criteria: not described
Interventions Surgical intervention: Laser-assisted cataract surgery using the LenSx (AlconLaboratories
Inc) or manual phacoemulsification (phacoemulsification system not described)
Outcomes Capsulotomy/capsulorhexis circularity and postoperative spherical equivalent
Notes Funding source: not reported.
Declaration of interest: “The authors declare no conflicts of interest”
Date study conducted: October 2013 to January 2014
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The method of sequence generation is not described
Allocation concealment (selection bias) Unclear risk The method of allocation concealment is not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study methodology de-
scribed. No masking of participants is described
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Hida 2014 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No masking of the outcome assessment is described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There is no reporting of reporting of data attrition to permit
judgement
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
Kovacs 2014
Methods Parallel-group RCT
Participants Number of participants randomised: 79 (40 laser arm, 39 control arm)
Number of eyes included: 79 (40 laser arm, 39 control arm)
Country: Hungary
Average age: 66 years laser arm, 69 years control arm
Sex: 70% female laser arm, 74% female control arm
Ethnic group: not described
Inclusion criteria: only exclusion criteria are given
Exclusion criteria: “previous ocular surgery, trauma, active ocular disease (eg. pseudoexfoli-
ation syndrome and uveitis), poorly dilated pupils, or known zonular weakness ”
Interventions Surgical intervention: Laser-assisted cataract surgery using the LenSx (Alcon Laborato-
ries, Inc.) or manual phacoemulsification using the Infinity Vision System (Alcon Lab-
oratories, Inc.)
Outcomes Subgroup analysis of previous RCT (no further data on this given). Primary outcome
measure: quantification of posterior capsule opacification at 18-26 months postopera-
tively. Additional data: intraocular lens tilt and decentration
Notes “All patients from a previous prospective, randomised study on femtosecond laser surgery with
a minimum follow-up time of 18 months were identified in our database and their data were
processed for further statistical analyses.”No publication reference is given for the original
RCT
Funding source: not reported
Declaration of interest: “Drs. Nagy, Donnenfeld, and Knorz are consultants of LenSx Lasers,
Inc. The remaining authors have no financial or proprietary interest in the materials presented
herein”
Date study conducted: not reported
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
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Kovacs 2014 (Continued)
Random sequence generation (selection
bias)
Unclear risk Themethod of sequence generation is not described. Patients in-
cludedwere those with aminimum follow-up time of 18months
from a previous RCT
Allocation concealment (selection bias) Unclear risk The method of allocation concealment is not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study methodology de-
scribed. No masking of participants is described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Masking of the outcome assessment is described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There is no reporting of reporting of data attrition to permit
judgement
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
Kranitz 2012
Methods Parallel-group RCT
Participants Number of participants randomised: 45 (20 laser arm, 25 control arm)
Number of eyes included: 45 (20 laser arm, 25 control arm)
Country: Hungary
Average age: 64 years laser arm, 68 years control arm
Sex: 75% female laser arm, 92% female control arm
Ethnic group: not described
Inclusion criteria: only exclusion criteria are given
Exclusion criteria: “Patients with previous ocular surgery, trauma, active ocular disease,
poorly dilated pupils, or known zonular weakness were excluded from the study”
Interventions Surgical intervention: Laser-assisted cataract surgery using the LenSx (Alcon Laborato-
ries, Inc.) or manual phacoemulsification using the Accurus phacoemulsification ma-
chine (Alcon Laboratories, Inc.)
Outcomes Intraocular lens decentration and tilt, Refraction, UDVA and CDVA
Notes Funding source: not reported.
Declaration of interest: “Drs Knorz and Nagy are consultants to Alcon LenSx Inc. The
remaining authors have no financial interest in the materials presented herein.”
Date study conducted; not reported
Trial registration number: not reported
Risk of bias
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Kranitz 2012 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was done using computer-generated tables
Allocation concealment (selection bias) Unclear risk Randomisation was done using computer-generated tables
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study methodology de-
scribed. No masking of participants is described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No masking of the outcome assessment is described.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There is no reporting of reporting of data attrition to permit
judgement
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
Mastropasqua 2014a
Methods Parallel-group RCT
Participants Number of participants randomised: 60
Number of eyes included: 60 (right eyes)
Country: Italy
Average age: 70 years
Sex: not described
Ethnic group: not described
Inclusion criteria: “age between 65 and 75 years, axial length between 23.0 and 24.0 mm,
corneal astigmatism less than 2.00 diopters (D), nuclear cataract of grade 2 to 3 (nuclear
opalescence 3/4) (Lens Opacities Classification System III), and corneal en- dothelial cell
count greater than 1,200/mm ”
Exclusion criteria: “pathological alterations of the anterior segment (eg, corneal opacities,
keratoconus, chronic uveitis, zonular dialysis, pseudoexfoliation syndrome, glaucoma, and
diabetes mellitus), other ocular pathologies impairing visual function, previous anterior or
posterior segment surgery, and intraoperative or postoperative complications”
Interventions Surgical intervention: Laser-assisted cataract surgery using the LenSx platform (Alcon
Inc, FortWorth,TX,USA) ormanual phacoemulsificationusing theAlconConstellation
System (Alcon Laboratories, Inc.)
Outcomes UDVA and CDVA (logMAR), keratometric astigmatism, corneal endothelial cell count,
corneal thickness at the incision site and higher order corneal aberrations. Follow-up was
6 months
33Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mastropasqua 2014a (Continued)
Notes Funding source: not reported
Declaration of interest: “The authors have no financial or proprietary interest in thematerials
presented herein”
Date study conducted: not reported
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The method of sequence generation is not described
Allocation concealment (selection bias) Unclear risk The method of allocation concealment is not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study methodology de-
scribed. No masking of participants is described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No masking of the outcome assessment is described
Incomplete outcome data (attrition bias)
All outcomes
Low risk Based on the number of eyes reported in Figure 1, there was no
loss to follow-up
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
Mastropasqua 2014b
Methods Parallel-group RCT
Participants Number of participants randomised: 90
Number of eyes included: 90
Country: Italy
Average age: 69 years
Sex: not described
Ethnic origin: not described
Inclusion criteria: The inclusion criteria were age between 65 years and 75 years, nuclear
cataract grade 3 to 4 (nuclear opalescence [NO] 3/4 on Lens Opacities Classification
System III), and a corneal endothelial cell count greater than 1200 cells/mm2
Exclusion criteria: poor pupil dilation, pathology that could alter the anterior segment
(e.g. corneal opacities, keratoconus, chronic uveitis, zonular dialysis, pseudoexfoliation
syndrome, glaucoma, diabetes), other ocular pathology that can impair visual function,
previous anterior or posterior segment surgery, and intraoperative or postoperative com-
plications
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Mastropasqua 2014b (Continued)
Interventions Participants were randomised to one of 3 treatments with equal probability for each
group:
a) laser-assisted cataract surgery using a Lensx femtosecond laser (Alcon Laboratories
Inc); the capsulotomy, lens fragmentation and corneal incisions were performed using
the femtosecond laser
b) laser-assisted cataract surgery using a Lensar femtosecond laser (Lensar Inc); the cap-
sulotomy and lens fragmentation were performed using the
femtosecond laser
c) manual phacoemulsification
Outcomes Difference in the distance between the intraocular lens centroid and the pupil centroid
180 days after surgery, visual parameters, refractive parameters, circularity, capsulorhexis
area, intraocular lens centroid-pupil centroid distance, and capsulorhexis centroid-pupil
centroid distance)
Notes Funding source not reported
Declaration of interest: “No author has a financial or proprietary interest in any material
or method mentioned”
Date study conducted: not reported
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A computer-generated, 6-block, 15-patient randomisation list
was generated using an in-house closed-source software devel-
oped in Matlab 2009b. Patients were assigned to 1 of
the 3 treatments with an equal probability for each group
Allocation concealment (selection bias) Unclear risk The method of allocation concealment is not described
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The trialmethodology states: “The surgeon and the operating room
staff were aware of group assignment. The patients were masked to
group assignment until the study was completed.” However it is
unclear how the patients could remain masked unless sham laser
was performed, and there is no description of this
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “examiners performing preoperative and postoperative assessments
were masked to group assignment until the study was completed”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Based on the results (“Each group comprised 30 eyes (30 pa-
tients)”), it would appear that no patients were lost to follow-up
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
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Nagy 2011
Methods Parallel-group RCT
Participants Number of participants randomised: 105 (53 laser arm, 52 control arm)
Number of eyes included: 111 (54 laser arm, 57 control arm)
Country: Hungary
Average age: 65 years old laser group, 68 years old control group
Sex: 72% female laser group, 70% female control group
Ethnic group: not described
Inclusion criteria: only exclusion criteria are given
Exclusion criteria: “Patients with previous ocular surgery, trauma, active ocular disease,
poorly dilated pupils, or known zonular weakness were excluded from the study”
Interventions Surgical intervention: Laser-assisted cataract surgery using the LenSx (Alcon Laborato-
ries, Inc.) or manual phacoemulsification using the Accurus phacoemulsification ma-
chine (Alcon Laboratories, Inc.)
Outcomes Circularity and area of capsulotomy and intraocular lens decentration
Notes Funding source: not reported
Declaration of interest: “Drs Nagy and Knorz are consultants to LenSx Lasers Inc. The
remaining authors have no proprietary interest in the materials presented herein”
Date study conducted: not reported
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Using computer randomisation, patients and their right/left eyes
were randomly selected for femtosecond and manual surgery
Allocation concealment (selection bias) Unclear risk Using computer randomisation, patients and their right/left eyes
were randomly selected for femtosecond and manual surgery
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study methodology de-
scribed. No masking of participants is described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No masking of the outcome assessment is described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There is no reporting of data attrition to permit judgement
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
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Nagy 2014
Methods Parallel-group RCT
Participants Number of participants randomised: 40 (20 laser arm, 20 control arm)
Number of eyes included: 40 (20 laser arm, 20 control arm)
Country: Hungary
Average age: 70 years laser group versus 62 years control group
Sex: not described
Ethnic group: not described
Inclusion criteria: only exclusion criteria are given
Exclusion criteria: “previous ocular surgery, trauma, active ocular disease, poorly dilated
pupils, or known zonular weakness were excluded”
Interventions Surgical intervention: Laser-assisted cataract surgery using the LenSx platform (Alcon
Laboratories Inc) or manual phacoemulsification (platform not described)
Outcomes Surgically induced astigmatism and corneal higher order aberrations. Additional data
reported: intraoperative and postoperative complications. Follow-up was 3 months
Notes Funding source: not reported
Declaration of interest: “Dr. Nagy is a consultant for Alcon Laboratories, Inc. The remaining
authors have no financial or proprietary interest in the materials presented herein”
Date study conducted: not reported
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was done using computer-generated tables
(Microsoft Excel; Microsoft Corporation, Redmond, WA)”
Allocation concealment (selection bias) Unclear risk The method of allocation concealment is not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study methodology de-
scribed. No masking of participants is described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No masking of the outcome assessment is described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There is no reporting of reporting of data attrition to permit
judgement
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
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Reddy 2013
Methods Parallel-group RCT
Participants Number of participants randomised: 131
Number of eyes: 131
Country: India
Average age: 59 years laser arm, 61 control arm
Sex: 46% female laser arm, 41% female control arm
Ethnic group: not described
Inclusion criteria: Eligible patients were at least 18 years old with clear corneal media
and elected to have routine cataract surgery”
Exclusion criteria for all patients:
• poorly dilating pupil or other pupil defect that prevents iris from adequate
retraction peripherally
• lens/zonule instability such as, but not restricted to, Marfan syndrome,
pseudoexfoliation syndrome
• previous intraocular or corneal surgery of any kind, including any kind of surgery
for refractive or therapeutic purposes in either eye
• known sensitivity to planned concomitant medications
• disorders of the ocular muscle, such as nystagmus or strabismus
• keratoconus
• wound-healing disorders, such as connective tissue disease, autoimmune illnesses,
immunodeficiency illnesses, ocular herpes zoster or simplex, endocrine diseases, lupus,
rheumatoid arthritis
• abnormal examination results from slitlamp, fundus, partial coherence
interferometry
• autoimmune disease, collagenosis, or clinically significant atopy
• pregnancy or nursing
Additional exclusion criteria for those having laser-assisted procedures:
• minimal and maximal K values in central 3.0mm zone that do not differ by more
than 5.0 D on a keratometric map of the cornea
• maximal K-value that does not exceed 60.0D and minimum value that is smaller
than 37.0 D
• corneal disease or pathology that precludes transmission of laser wavelength or
distortion of laser light
• abnormal examination results from scanning-slit corneal topography
• anterior chamber depth < 2.4 mm or > 4.5 mm measured by ultrasonic
examination
The study enrolled 131 patients (laser group, 64; manual group, 67)
Interventions Surgical intervention: Laser-assisted cataract surgery using the VICTUS™ platform
(Bausch & Lomb Technolas) or manual phacoemulsification using the Stellaris Vision
Enhancement System (Bausch & Lomb)
Outcomes Primary outcome measure: effective phacoemulsification time
Secondary outcome measures: mean phacoemulsification energy, mean phacoemulsifi-
cation time, volume of balanced salt solution, subjective surgeon assessment of ease of
phacoemulsification
Additional data reported: capsulotomy comparisons, intraocular lens decentration, safety
data including posterior capsule tear and iris damage
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Reddy 2013 (Continued)
Follow-up was limited to 1 day postoperatively
Notes Funding source: not reported
Declaration of interest: “Dr. Reddy has received travel and research grants from Technolas
Perfect Vision GmbH, Dr. Kandulla is an employee of Technolas Perfect Vision GmbH (a
Bausch & Lomb company), and Dr. Auffarth has received travel and research grants as well
as lecture fees from Technolas Perfect Vision GmbH/Bausch & Lomb”
Date study conducted: not reported
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not described, other than “open-label”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not described, other than “open-label”
Incomplete outcome data (attrition bias)
All outcomes
High risk One eye in the laser-assisted group was excluded from analysis
because of a protocol violation (no details of this are given). Also:
“During the clinical trial, it became evident that the P values of
all phacoemulsification parameters (EPT, mean phaco energy, mean
phaco time, and balanced salt solution volume) were both surgeon
dependent and cataract grade dependent. Evaluation by the Mann-
Whitney U test showed that median cataract grade between the 2
treatment groups was equal except for those operated on by 1 surgeon.
To ensure equal cataract grade distributions in the 2 study groups to
guarantee correct data analysis and rule out preoperative bias, 7 eyes
in the laser-assisted group and 4 in the manual group were excluded
from further analysis. This resulted in 56 eyes in the laser-assisted
group and 63 in the manual group that had subsequent analysis”
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
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Schargus 2015
Methods Within-person (paired-eye) RCT
Participants Number of participants randomised: 37
Number of eyes included: 74
Country: Germany
Average age: 72 years
Sex: 59% female
Ethnic group: not described
Inclusion criteria: had a visually significant cataract (NC2 to NC5 on the Lens Opacities
Classification System III [LOCS III]), corrected distance visual acuity (CDVA) decreased
0.1logMAR in both eyes, dilated pupil width of 6.0 mm or greater, and were willing to
volunteer for the trial after giving informed consent
Exclusion criteria: corneal scars, corneal diseases, corneal astigmatism of 1.5D or greater,
reduced endothelial cell count (ECC) (less than1500 cells/mm²),CCT less than500µm,
glaucoma, pseudoexfoliation syndrome, zonular weakness, single eye, malformations,
history of ocular surgery, intraocular tumours, active or past inflammations, age-related
macular degeneration, diabetic retinopathy, axial length difference (greater than 0.5
mm) and axial length less than 21.5 mm or greater than 26 mm, pregnancy, reduced
compliance, age younger than 22 years, or participation in another clinical study within
30 days of the preoperative visit
Interventions Laser-assisted cataract surgery using theCatalys platform (Catalys Precision Laser System,
AMO) ormanual phacoemulsification using a Stellaris phacomachine (Bausch&Lomb)
Outcomes Primary outcome measure: endothelial cell count before surgery and 3 and 6 months
postoperatively
Secondary outcome measurements included evaluation of corneal thickness, intraocular
pressure, CDVA, overall surgery time, and quantity of fluid passing through the eye
during surgery
Notes Funding source: not reported
Declaration of interest: “Dr Dick is a paid consultant for Abbott Medical Optics. The
remaining authors have no financial or proprietary interest in the materials presented”
Date study conducted: October 2012 to May 2013
Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Both treatment group allocations were printed on
a separate sheet, which were sealed in sequentially
numbered identical envelopes according to the ran-
domised allocation sequence
Allocation concealment (selection bias) Low risk The enclosed assignments were inserted into se-
quentially numbered, opaque, well sealed envelopes
for allocation concealment, which were continu-
ously monitored. Investigators ensured that the en-
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Schargus 2015 (Continued)
velopes were opened sequentially and only after the
participant’s name and other details were written on
the appropriate envelope
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study
methodology described. Nomasking of participants
is described
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Nomasking of the outcome assessment is described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There is no reporting of reporting of data attrition
to permit judgement
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry
(trial was not registered)
Takacs 2012
Methods Parallel-group RCT
Participants Number of participants randomised: 76
Number of eyes: 76
Country: Hungry
Average age: 67 years laser arm, 67 years control arm
Sex: 74% female laser arm, 61% female manual phacoemulsification arm
Ethnic group: not described
Inclusion criteria: only exclusion criteria stated
Exclusion criteria: “Patients showing low cooperation, dense (grade 4) or white cataract,
corneal scars or opacities, anterior segment abnormalities, floppy iris syndrome, and poor
pupillary dilation were not included in the study”
Interventions Laser-assisted cataract surgery using the LenSx femtosecond laser (Alcon Laboratories
Inc) or manual phacoemulsification using the Alcon Infinity phacoemulsification system
(Alcon Laboratories Inc)
Outcomes Postoperative central corneal oedema, endothelial cell count, and endothelial cell func-
tion expressed by volume stress index
Notes Funding source: not reported
Declaration of interest: “Drs Nagy and Knorz are consultants to Alcon LenSx Inc. The
remaining authors have no financial interest in the materials presented herein”
Date study conducted; February 2010 to February 2011
Trial registration number: not reported
Risk of bias
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Takacs 2012 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patients were randomly assigned (using computer randomisa-
tion) to either group by the surgeon (ZZN)
Allocation concealment (selection bias) Unclear risk No further details other than above
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study methodology de-
scribed. No masking of participants is described
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Examiners were not aware of which surgical procedure had been
used when performing the postoperative examinations
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There is no reporting of reporting of data attrition to permit
judgement
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
Yu 2015
Methods Parallel-group RCT
Participants Number of participants randomised: 36
Number of eyes: 54
Country: China
Average age: 62 years laser arm, 57 years control arm
Sex: not described
Ethnic group: not described
Inclusion criteria: Normal and transparent cornea; Pupillary diameter of at least 6mm
under dilation; Preoperative best corrected visual acuity worse than LogMAR 0.3
Exclusion criteria: No local or systematic contraindications for cataract surgery
Interventions Laser-assisted cataract surgery using the LENSAR femtosecond laser or manual pha-
coemulsification using the Bausch & Lomb Stellaris system
Outcomes Phacoemulsification time, energy, and complications during operation were recorded.
Postoperative refraction at 1 day, 1 week, 1 and 3 months, the capsulorhexis size and
corneal endothelial density at 1 and 3 months were also measured
Notes Funding source: funded by the International Cooperation Project of the Science and
Technology Bureau of Zhejiang province, China (Grant No. 2013C14010)
Declaration of interest: “All authors have completed and submitted the ICMJE Form for
Disclosure of Potential Conflicts of Interest and none were reported”
Date study conducted; October 2013 to November 2013
Trial registration number: not reported
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Yu 2015 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgeon masking is not feasible for the study methodology de-
scribed. No masking of participants is described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Corneal endothelial cell density and capsulorhexis size weremea-
sured by a masked examiner. No masking of other outcomes is
described
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There is no reporting of reporting of data attrition to permit
judgement
Selective reporting (reporting bias) Unclear risk No access to study protocol or trials registry entry (trial was not
registered)
CDVA: corrected distance visual acuity
D: diopters
RCT: randomised controlled trial
UDVA: uncorrected distance visual acuity
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Conrad-Hengerer 2012a Not a RCT
Conrad-Hengerer 2013b Not a RCT
Conrad-Hengerer 2014b Not a RCT
Ecsedy 2011 Not a RCT
Espaillat 2016 Not a RCT
Hatch 2015 Not a RCT
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(Continued)
Kerr 2013 Not a RCT
Kranitz 2011 Not a RCT
Krarup 2014 Although this is a within-person paired-eye study, eyes were not randomised to the intervention (”To
evaluate whether FLACS was superior to CPS regarding ECL, the eye with most dense cataract was
operated with femtosecond laser assisted cataract surgery and the eye with less cataract with conventional
cataract surgery”)
Nagy 2012 Insufficient information to confirm eligibility (conference abstract only), no mention of randomisation
to the intervention
Szigeti 2012 Both arms involved laser-assisted cataract surgery, no phacoemulsification control arm
Toto 2015 Not a RCT
Wang 2015 Unable to source a copy of the paper from either the journal website or the contact author
RCT: randomised controlled trial
Characteristics of ongoing studies [ordered by study ID]
ISRCTN77602616
Trial name or title The FACT trial: a randomised comparison of femtosecond laser-assisted vs. manual phacoemulsification
cataract surgery for adults with visually significant cataract
Methods Allocation: randomised
Participants 808
Interventions Arm A: manual phacoemulsification cataract surgery in the study eye
Arm B: laser-assisted phacoemulsification cataract surgery in the study eye
Outcomes Primary outcome measures
Unaided distance visual acuity (UDVA, logMAR) at 3 months following surgery in the study eye measured
using a standard ETDRS chart at a distance of 4 metres
Secondary outcome measures
1. Unaided distance visual acuity (UDVA) in the study eye at 12 months after surgery
2. Corrected distance visual acuity (logMAR) at 3 and 12 months after surgery in the study eye (ETDRS
logMAR chart at 4 metres)
3. Ocular complications within 3 and 12 months of surgery in the study eye (and second eye). A complication
will be defined as any event that causes unintentional injury to an ocular structure, or requires additional
treatment, or has a negative effect on a patient’s health or eyesight
4. Unaided and corrected visual distance acuity and complications in the second eye (for those with bilateral
cataracts), and with both eyes open at 3 and 12 months after surgery
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ISRCTN77602616 (Continued)
5. Percentage of patients within 0.5 and within 1 dioptre of intended refractive outcome
6. Patient-reported outcomes measures: vision health status using Rasch validated patient-reported outcome
measures at 3 and 12 months: (Catquest-9SF)
7. Cost-utility analysis: within-trial cost-effectiveness analyses at 3 and 12 months and expected cost- effec-
tiveness over patient lifetime. The analysis will conform to accepted economic evaluation methods and will
use the EQ-5D-3L+vision bolt-on question (EQ-5DV)
8. Corneal endothelial cell count change (additional safety measure) at 3 and 12 months
Starting date 01/05/2015
Contact information ctu.fact@ucl.ac.uk
Notes Overall trial end date: 28/02/2018
NCT01693211
Trial name or title Prospective evaluation of circularity and diameter of femtosecond laser versus manual anterior capsulotomy
in Singapore National Eye Centre
Methods Allocation: randomised
Endpoint classification: efficacy study
Intervention model: parallel assignment
Masking: open-label
Primary purpose: treatment
Participants 48
Interventions Device: femtosecond laser (VICTUS™ femtosecond laser platform)
Device: manual phacoemulsification cataract surgery (continuous curvilinear capsulorrhexis technique with
Utrata forceps)
Outcomes Primary outcome measure: circularity of created rhexis
Secondary outcome measure: diameter of the created rhexis
Other outcome measure: centration of the created rhexis relative to the pupil
Starting date September 2012
Contact information Principal investigator: Soon Phaik Chee, Assoc Prof, Singapore National Eye Center
Notes Study completion date: June 2014
No study results posted
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NCT01769313
Trial name or title A single centre study to analyze cataract surgery following femtosecond laser-assisted and manual cataract
surgery
Methods Allocation: randomised
Endpoint classification: efficacy study
Intervention model: parallel assignment
Masking: single-blind (caregiver)
Primary purpose: treatment
Participants 30
Interventions Device: laser-assisted cataract surgery
Device: manually performed cataract surgery
Outcomes Capsulotomy overlap, effective lens position, difference in pre- to postoperative flare, refractive outcome
prediction error
Starting date January 2013
Contact information Principal investigator: Gerd U Auffarth, Prof. Universitäts-Augenklinik Heidelberg
Notes Study completion date: October 2014
No study results posted
NCT01971177
Trial name or title A multi-centre, multi-surgeon, randomised, controlled, prospective, post-market clinical follow-up study to
investigate the impact of cataract grade on the efficacy and safety of femtosecond laser-assisted lens fragmen-
tation procedure
Methods Allocation: randomised
Endpoint classification: safety/efficacy study
Intervention model: parallel assignment
Masking: open-label
Primary purpose: treatment
Participants 136
Interventions Device: femtosecond laser cataract surgery
Procedure: manual cataract surgery
Outcomes Primary outcome measures: effective phacoemulsification time
Secondary outcome measures: adverse events
Starting date October 2013
Contact information Principal investigator: Pavel Stodulka, Dr. med Gemini clinic, Zlin, Czech Republic 76001
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NCT01971177 (Continued)
Notes Study completion date: February 2014
No study results posted
NCT01982006
Trial name or title Impact médico-economique de la chirurgie de la cataracte au laser femtoseconde
Methods Allocation: randomised
Endpoint classification: safety/efficacy study
Intervention model: parallel assignment
Masking: single blind (subject)
Primary purpose: treatment
Participants 1050
Interventions Procedure: cataract surgery with phacoemulsification
Device: femtosecond laser-assisted cataract surgery
Outcomes Primary outcome measures:
• incremental cost/effectiveness ratio defined as cost per incremental therapeutic success
Therapeutic success will be defined by the association of the following criterion
• No severe intraoperative or postoperative complications
• Best Corrected Visual Acuity of 0 LogMAR
• A refractive error inferior or equal to 0.75 diopter
• Corneal surgically-induced astigmatism inferior or equal to 0.5 diopter and a postoperative change of
astigmatism axis inferior or equal to 20°
Secondary outcome measures:
• quality of life
• quality of life evaluation using Visual Function 14 questionnaire
• learning curve of the femtosecond laser-assisted cataract surgery
• overall costs of cataract surgery in both arms from the hospital perspective
• incremental cost-utility ratio defined as incremental cost/QALY (Quality Adjusted Life Year) for
healthcare insurance in both arms
• no severe intraoperative or postoperative complications
• best corrected visual acuity of 0 LogMAR
• refractive error inferior or equal to 0.75 diopter
• corneal surgically-induced astigmatism inferior or equal to 0.5 diopter and a postoperative change of
astigmatism axis inferior or equal to 20°
Starting date October 2013
Contact information Principal investigator: Cédric SCHWEITZER, University Hospital Bordeaux, France
Notes Estimated study completion date: April 2016
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NCT01991717
Trial name or title An open-label investigator-masked study comparing femtosecond laser assistedwith conventional phacoemul-
sification cataract surgery
Methods Allocation: randomised
Intervention model: parallel assignment
Masking: single-blind (investigator)
Primary purpose: treatment
Participants 50
Interventions Device: VICTUS™
Device: conventional phacoemulsification
Outcomes Primary outcome measures: effective phacoemulsification time
Secondary outcome measures: intraocular lens overlap, intraocular lens centration
Other outcome measures: patient subjective perception, effects on the cornea and retina as assessed by optical
coherence tomography (OCT), pentacam or endothelial cell count
Starting date December 2013
Contact information Principal investigator: Matthias Bolz, AKh Linz, Ophthalmology
Notes Estimated study completion date: January 2015
NCT02110212
Trial name or title A prospective, randomised study of cataract surgery with the assistance of the OptiMedica femtosecond
laser system compared to standard surgical procedure of continuous curvilinear capsulorhexis and ultrasonic
phacoemulsification
Methods Allocation: randomised
Endpoint classification: safety/efficacy study
Intervention model: parallel assignment
Masking: open-label
Primary purpose: treatment
Participants 17
Interventions Procedure: ultrasound surgery and continuous curvilinear capsulorrhexis
Device: femtosecond laser surgery
Outcomes Primary outcome measure: capsulotomy dimension
Secondary outcome measure: cumulative dissipated energy
Starting date April 2011
Contact information Principal investigator: Juan F. Batlle, Laser Center, Santo Domingo, Dominican Republic
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NCT02110212 (Continued)
Notes Study completion date: February 2014
No study results posted: this study has been terminated
NCT02351271
Trial name or title A single centre randomised eye study to compare the performance and safety of femtosecond laser-assisted
cataract procedures with conventional ultrasound-assisted cataract surgery
Methods Allocation: randomised
Endpoint classification: safety/efficacy study
Intervention model: parallel assignment
Masking: open-label
Primary purpose: treatment
Participants 130
Interventions Device: Femto LDV Z8
Device: manual capsulorhexis and lens fragmentation
Outcomes Primary outcome measure: effective phacoemulsification time
Secondary outcome measures: ease of phacoemulsification, completeness of capsulotomy
Other outcome measures: safety outcomes
Starting date February 2015
Contact information Principal investigator: Bojan Pajic, Augenzentrum ORASIS AG
Notes Estimated study completion: September 2016
NCT02403206
Trial name or title Femtosecond laser assisted cataract surgery in intumescent cataracts
Methods Allocation: randomised
Endpoint classification: safety study
Intervention model: parallel assignment
Masking: open-label
Primary purpose: treatment
Participants 425
Interventions Device: femtosecond laser
Procedure: continuous curvilinear capsulorhexis
Outcomes Primary outcome measure: percentage of capsular tears (anterior or posterior)
Secondary outcome measure: operating time
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Starting date March 2015
Contact information Study director: Kristi Rushin, Alcon Research
Notes Estimated study completion date: August 2016
NCT02492659
Trial name or title Clinical research of femtosecond laser-assisted cataract surgery: randomised clinical trial
Methods Allocation: randomised
Intervention model: single group assignment
Masking: single-blind (investigator)
Primary purpose: treatment
Participants 54
Interventions Procedure: femtosecond laser-assisted cataract surgery
Procedure: conventional phacoemulsification
Outcomes Primary outcome measure: the proteins in the aqueous humor after femtosecond laser operation
Secondary outcome measures: the electrolyte in the aqueous humor after femtosecond laser operation; mor-
phology of the anterior capsule after femtosecond laser operation
Other outcome measures:
• phacoemulsification energy
• phacoemulsification time
• postoperative refraction
• the capsulorhexis size
• corneal endothelial density
Starting date October 2013
Contact information Principal investigator: A-Yong Yu, Wenzhou Medical University
Notes Study completion date: June 2014
NCT02561104
Trial name or title Outcomes of resident-performed laser-assisted versus manual traditional phacoemulsification
Methods Allocation: randomised
Endpoint classification: safety/efficacy study
Intervention model: parallel assignment
Masking: open-label
Primary purpose: treatment
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Participants 180
Interventions Procedure: laser-assisted cataract surgery
Procedure: traditional manual phacoemulsification
Outcomes Primary outcome measures:
• complication rates
• bilateral best spectacle corrected visual acuity
Secondary outcome measures:
• patient benefit perception
• corneal endothelial cell count
• lens removal time
Starting date September 2015
Contact information Bonnie Miller, University of Texas Southwestern Medical Center
Notes Estimated study completion date: January 2017
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D A T A A N D A N A L Y S E S
Comparison 1. Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Intraoperative complications 10 Odds Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Anterior capsule tear 10 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Posterior capsule tear 10 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Visual acuity 5 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Corrected distance visual
acuity 1 week
3 204 Mean Difference (IV, Random, 95% CI) -0.05 [-0.10, 0.01]
2.2 Corrected distance visual
acuity 1-3 months
5 412 Mean Difference (IV, Random, 95% CI) -0.00 [-0.03, 0.02]
2.3 Corrected distance visual
acuity 6 months or more
3 224 Mean Difference (IV, Random, 95% CI) -0.03 [-0.05, -.00]
2.4 Uncorrected distance
visual acuity 1 week
2 150 Mean Difference (IV, Random, 95% CI) -0.03 [-0.19, 0.14]
2.5 Uncorrected distance
visual acuity 1-3 months
2 150 Mean Difference (IV, Random, 95% CI) -0.03 [-0.21, 0.15]
2.6 Uncorrected distance
visual acuity 6 months or more
2 150 Mean Difference (IV, Random, 95% CI) -0.06 [-0.26, 0.14]
3 Total duration of procedure 3 274 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.02, 0.21]
4 Postoperative complications 10 Odds Ratio (M-H, Random, 95% CI) Subtotals only
4.1 Cystoid macular oedema 9 957 Odds Ratio (M-H, Random, 95% CI) 0.58 [0.20, 1.68]
4.2 Elevated intraocular
pressure (up to 1 day after
surgery)
9 1022 Odds Ratio (M-H, Random, 95% CI) 0.88 [0.29, 2.66]
4.3 Elevated intraocular
pressure (1 day to 1 week after
surgery)
8 903 Odds Ratio (M-H, Random, 95% CI) 0.57 [0.11, 2.86]
5 Refractive outcomes - mean
absolute error
3 278 Mean Difference (IV, Fixed, 95% CI) -0.18 [-0.27, -0.09]
C O N T R I B U T I O N S O F A U T H O R S
ACD and CB contributed to the concept, design and writing of the protocol. DMG contributed to the design and provided feedback
for the protocol. ACD and DMG reviewed the titles and abstracts from the electronic literature searches and extracted data from these
for the review. JE assisted with data analysis and write-up. All authors contributed to responding to editorial and peer review comments,
and approved the final version of the review for publication.
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ongoing FACT trial (ISRCTN77602616).
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The differences between the Day 2013 protocol and the review are summarised below.
We changed the title to “Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery”. The title
previously was “Laser assisted versus manual phacoemulsification for lens extraction.”
We modified the outcomes to include outcomes of relevance to the proposed National Institute for Health and Care Excellence (NICE)
Cataract Surgery Guidelines. In particular we included refractive outcomes (including deviation from the predicted refractive outcome),
we included patient-reported outcomes such as satisfaction, and included resources used, such as total duration of procedure, in addition
to costs.
We added the methods for GRADE assessment that were not included in the original protocol.
Some planned methods could not be performed because there were too few trials supplying relevant data. We therefore did not do any
subgroup analysis according to type of laser system used and we did not do a sensitivity analysis excluding trials at high risk of bias.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
Anterior Capsular Rupture, Ocular [etiology]; Cataract Extraction [adverse effects; ∗methods]; Laser Therapy [adverse effects;
∗methods]; Macular Edema [etiology]; Ocular Hypertension [etiology]; Phacoemulsification [adverse effects; methods]; Posterior Cap-
sular Rupture, Ocular [etiology]; Randomized Controlled Trials as Topic; Visual Acuity
MeSH check words
Adult; Humans
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